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EXTENDED ABSTRACT 
 
The preparation of Nanostructures of desired shape, composition 
and with tailored properties is of wide scientific and technological 
interest. Indeed, a variety of nanoparticle architectures have been 
proposed as nanocarriers, these include liposomes, quantum dots 
(QD), gold-nanoshells, mesoporous materials, micelles, magnetic 
nanoparticles, dendrimers, and Carbon Nanotubes (CNTs) as so as  
several materials have been studied for use in active agents 
targeting. Among them, as asserted by different authors, hollow 
biopolymeric nanocapsules or (nanoencapsulated systems) as active 
substance carriers, compared to other particulated systems, show 
higher drug encapsulation efficiency due to optimized drug solubility 
in the core, low polymeric content compared such as to nanospheres, 
drug polymeric shell protection against degradation factor like pH 
and light and the reduction of tissue irritation due to the polymeric 
shell. 
 Several research teams have extensively studied the 
nanoparticles formation mechanism, and generally there are several 
classical methods for the preparation of nanocapsular systems: 
nanoprecipitation, emulsion diffusion, emulsion evaporation, double 
emulsification, emulsion coacervation, polymer coating and layer by 
layer.  
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Despite the fact the research proposed on these methods has shown 
important strategies, all these methods present critical challenges 
with a view of the industrial development. Indeed, it is important to 
take into account that the method chosen should also considerer 
other aspects such as active substance stability under operational 
conditions, particularly stirring, encapsulation efficiency, method 
feasibility, the generation of contaminants and the need for 
subsequent purification steps, solvent nature, the water volume 
required and time consumption. Likewise, the feasibility of scaling-up 
and cost should be considered. 
In these perspectives, to overcome some limitations of traditional 
processes in nanocapsular structure productions, such as sufficient 
scale-up to produce the cost reduction required to target volume 
markets and more complicated procedure not suitable to be 
industrialized, we focused our attention on the three main 
approaches:  
- the first one based on the Thermally Induced Phase Separation 
(TIPS) to produce nanocapsules for therapy 
- the second one related to the study of the micellization of block-
copolymer to apply in the field of enhanced MRI 
- the last is the combining of the previous approaches by 
providing the deposition of the block-copolymer on the surface 
of the obtained nanocapsules. 
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In the first part of the thesis, we developed a novel approach 
based on the thermodynamics of Thermally Induced Phase 
Separation (TIPS) to produce semicrystalline nanocapsules. 
Thermally Induced Phase Separation has extensively been used to 
fabricate various porous biodegradable scaffolds suitable for tissue 
engineering and drug delivery, even though it has never been 
studied neither to produce nanocapsules nor to produce 
semicrystalline nanocapsules. Because of the variety of parameters 
involved in TIPS process, such as types of polymers, polymer 
concentration, solvent/nonsolvent ratio, and quenching temperature, 
we individuate in this approach the possibility to create a value 
added process enables to overcome the issues related to the 
production of the nanocapsular systems even by preserving 
fundamental architectural properties.  
In this process, we started by a Poly-L-Lactic Acid (PLLA), a 
biopolymer largely studied by TIPS. PLLA is a Food&Drug 
Administration Approved polymer and it is biocompatible and 
biodegradable material which undergoes scission in the body to 
monomeric units of lactic acid as a natural intermediate in 
carbohydrate metabolism. The work also investigates 
thermodynamic parameters involved in the process able to induce 
for the first time simultaneously bending and crystallization of 
polymeric chain to form a nanocapsule. An explanation of this 
unusual crystallization phenomenon will be described in term of 
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nanoscopic confinement of long flexible chain. Knowledge of the 
phase behavior of confined long flexible chain is a prerequisite to 
support the current interest in the construction of nanoscopic 
devices as so in conﬁnement altering the statistical mechanical 
properties of DNA. 
In the second part of the thesis a Block copolymers of poly 
lactic acid (PLA) and polyethylene glycol (PEG) has been studied. 
Block copolymer are few of the commonly used polymers with 
hydrophilic and hydrophobic blocks which allows the formation of a 
stable nano-particulate suspension in an aqueous solvent, where PLA 
chains predominantly form the core and PEG chains are located 
outside. A systematic variation in their chemical structure, 
composition, size, and architecture; block copolymers offer 
advantages in tuning their shape and functionality in comparison to 
conventional amphiphiles such as low molecular weight surfactants 
and lipids. In particular, Diblock PLA-PEG copolymers and triblock 
PLA-PEG-PLA copolymers allow modulation of the biodegradation 
rate, the hydrophilicity, and the mechanical properties of the 
copolymers. Herein we present temperature/time-reliant self-
assembly driven simple approach for the development of 
biocompatible nanostructures for MRI. Endeavor of the present 
research was to develop Gd loaded PLA-PEG-PLA NPs as the 
molecular MRI contrast agents to efficiently target tumor. A low 
molecular PLA-PEG-PLA have been designated to prepare well-
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demarcated NPs through optimization of kinetics of the self-
assembly viz a viz temperature/time/concentration. The 
hydrophobic/hydrophilic moieties of block copolymer nanoparticles 
(BCN) were employed to adsorb GD+3 at the surface of BCNs to 
achieve multifunctional biodegradable NPs for MRI. The 
paramagnetic properties of the BCNs designed here compare 
sympathetically with Gd-based agents that have previously been 
reported. For example, while relaxivity of the commercial products, 
such Magnevist is of 4 mM-1 sec
-1, our micelles can reach relaxivitry of 
around 30 mM-1 sec-1 , indicating a relaxivity significantly higher than 
the common paramagnetic contrast agents. 
Last part of the thesis has been devoted to the combination 
of the previous obtained structures in order to apply these new 
nanostructures in the theranostic field. For this reason only some 
Caolrimetric studies were performed. Nano-Isothermal Calorimetry 
(NanoITC) was used to evaluate the deposition of the block on the 
surface of the nanoparticles while Differential Scanning Calorimetry 
was used to show the melting properties of the combined system. 
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CHAPTER I: INTRODUCTION 
NANOPARTICLE FOR THERAPY AND DIAGNOSTIC: 
ARCHITECTURE AND FEATURES 
 
Theranostic is an emerging and promising field of the nanomedicine 
that has captured the interest of researchers because its purpose is 
to diagnose and treat the diseases at their earliest stage, when the 
diseases are most likely curable or at least treatable1. To achieve this, 
it takes advantage of the high capacity of nanoparticles, submicron 
sized colloidal particles with sizes ranging from 10-1000 nm in 
diameter, to ferry cargo and loads onto them both imaging and 
therapeutic functions. Thus, nanoparticle technologies are 
significantly impacting on the development of both therapeutic and 
diagnostic agents for simultaneous drug delivery and molecular 
imaging. 
From the point of view of Drug delivery, nanoparticle objective is the 
delivery of a medicine to its site of therapeutic action because this is 
one of the main limitations of pharmaceutical and biotechnology 
industries2. Indeed, most of the drugs are limited by their poor 
solubility, high toxicity and dosage, aggregation due to poor 
solubility, nonspecific delivery, in vivo degradation and short 
circulating half-lives. Thus, nanoparticles have the potential to 
overcome this limitations and could improve the process of releasing 
of a bioactive agent at a specific rate and at a specific site, allowing to 
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exploit thousands of new therapeutics that are limited by a safe and 
effective drug-delivery system.  
Although nanoparticles have been developed for a myriad of 
important diseases, the thrust of research has been focused on solid 
tumors, cardiovascular diseases, and immunological diseases. In 
particular, as drug carriers for chemotherapeutics, nanoparticles can 
be used to deliver medication directly to the tumor while sparing 
healthy tissue, by bringing several advantages over conventional 
chemotherapy3, because they can: 
• Protect drugs from being degraded in the body before they reach 
their target; 
• Enhance drug absorption into tumors and the cancerous cells 
themselves; 
• Allow for better control over the timing and distribution of drugs to 
the tissue, making it easier for oncologists to assess how well they 
work; 
• Prevent drugs from interacting with normal cells, thus avoiding side 
effects. 
Along with drug delivery researches other studies have been done for 
diagnostic applications. In particular, for molecular imaging, that 
allows the characterization of biological processes at the cellular and 
subcellular levels in intact organism by exploiting specific molecular 
probes or contrast agents, most of the contrast agents currently in 
use consist of low molecular weight compounds that are non-specific, 
thus making the quantification of disease at early stage difficult4. So, 
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the development of nanoparticulate-based contrast agents could 
offers a platform to enhance tissue specificity and sensitivity required 
for in vivo molecular imaging with a minimal administration of the 
contrast agent.  
One significant challenge for the successful development of 
therapeutic nanoparticles is rapid clearance during systemic 
delivery5. When nanoparticles enter the bloodstream, the particle 
surface may experience nonspecific protein adsorption 
(opsonization), thereby making them more visible to phagocytic cells. 
After opsonization, nanoparticles could be rapidly cleared from the 
bloodstream through phagocytosis by the reticuloendothelial system 
(RES) in the liver and by spleen filtration. Therefore, the factors that 
could affect the clearance and biodistribution of nanoparticles, such 
as particle physicochemical properties and targeting ligand 
functionalization, should be carefully considered for the optimal 
design of therapeutic nanoparticles. On the basis of physiological 
parameters such as hepatic filtration, tissue extravasation/diffusion, 
and kidney excretion, it is clear that particle size plays a key factor in 
the long circulation and biodistribution of nanoparticles. Indeed, 
nanoparticles smaller than 10 nm can be rapidly cleared by the 
kidneys or through extravasation, while larger nanoparticles may 
have higher tendency to be cleared by cells of reticuloendothelial 
system (RES). Moreover, It was observed that nanoparticles <100 nm 
have a higher potential to circulate in the blood for long periods of 
time and experience reduced hepatic filtration. Nanoparticle size also 
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plays a key role in tumor accumulation through the EPR effect 
(Enhanced Permeability and Retention effect)6. This is a phenomenon 
due to the unique anatomical and pathophysiological characteristics 
of solid tumor. Namely, in contrast to normal tissues and organs, 
most solid tumors show a higher vascular density, and tumors blood 
vessels present defective architecture, such as large gap between 
endothelial cells (e.g., ~ 1μm), lack of smooth muscle layers, so that 
macromolecules will have the opportunity to escape from tumor 
blood vessels and accumulate selectively in tumor tissues, whereas 
they could not cross normal blood vessels which will result in less 
side effects. In addition, defected lymphatic function that is 
important for the recovery of macromolecules in tissues is always 
found in tumor tissues. Consequently, once macromolecules 
accumulate in tumor tissues, they will not be cleared from tumor 
tissues but retain there for long time. Several studies have tried to 
determine the gap size in the leaky vasculature that depends on the 
kind of tumor considered. Therefore, to capitalize on the EPR effect 
and to efficiently escape from the physiological barriers, many 
studies advocate the optimal nanoparticle size range of 
approximately 10–250 nm. 
It has been established that the surface charge of nanoparticles is 
another important property because it could affect their uptake by 
the RES cells7. Neutrally charged particles have demonstrated much 
lower opsonization rates than charged particles. It was found that 
positively charged nanoparticles generate a higher immune response 
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compared to neutral or negatively charged nanoparticle 
formulations. For example, nanoparticles with a primary amine at the 
surface promote higher rates of phagocytic uptake when compared 
to those having sulfate, hydroxyl, or carboxyl groups at the surface. 
Many studies suggest that the optimal range of nanoparticle surface 
charge should be between −10 and +10 mV for reduced phagocytosis 
and minimized nonspecific interactions of nanoparticles. Surface 
modification of nanoparticles with PEG, which has favorable intrinsic 
physicochemical properties (e.g., high flexibility and hydrophilicity, 
low toxicity and immunogenicity), was found to reduce nanoparticle 
accumulation in off-target organs such as liver and spleen8. A PEG 
decoration on the nanoparticle’s surface shields hydrophobic or 
charged particles from being attacked by blood proteins, leading to 
prolonged circulation half-life compared to non-PEGylated 
nanoparticles. The length, shape, and density of PEG chains on the 
nanoparticle surface largely affect its surface hydrophilicity and 
phagocytosis.  
Until now, different architectures of nanoparticles have been 
developed using a variety of materials including lipids (liposomes), 
organometallic compound (nanotubes) and polymers (micelles, 
dendrimers and polymeric nanoparticles)9. 
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Figure 1. Different architectures applied in the nanomedicine field 
Liposomes 
Liposomes are artificial, single, or multilaminar vesicles made with 
bilayered membrane structures with inner aqueous phases, 
composed of natural or synthetic amphiphilic lipid molecules. They 
are versatile and tunable vehicles for drug delivery and imaging. 
Liposomes exhibit several unique properties including favorable 
safety profiles, long systemic circulation half-life, and ease of surface 
modifications. Among the clinically validated nanotechnology 
products, liposomal drugs were the first nanotherapeutics to get FDA 
approval for clinical use. Upon intravenous injection, these 
nanoparticles are rapidly cleared from the bloodstream by the 
reticuloendothelial defence mechanism, regardless of particle 
composition. Moreover, instability of the carrier and burst drug 
release, as well as non-specific uptake by the mononuclear 
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phagocytic system (MPS), provides additional challenges for 
translating these carriers to the clinic. Other challenges facing the use 
of liposomes in the clinic include the high production cost, fast 
oxidation of some phospholipids, and lack of controlled-release 
properties of encapsulated drugs. 
Micelles 
Micellar nanoparticles are attractive structures for carriers of drug 
and contrast agents because they can form relatively uniform size 
structures. They can be prepared by self-assembly of a variety of 
amphiphilic materials that, in aqueous environments, under certain 
concentrations and temperature, spontaneously self-assemble into 
core-shell nanostructure, with a hydrophobic core and a hydrophilic 
shell. This architecture increases the solubility of hydrophobic 
molecules, and allows incorporating multiple functionalities into a 
single structure. Polymeric micelles represent a class of micelles that 
are formed of block copolymers consisting of a hydrophobic block 
that forms the micellar core, and a hydrophilic portion that forms the 
corona. This corona (commonly consisting of PEG or equivalent 
hydrophilic polymer) confers these micelles with biocompatibility, 
stealth-like properties, and a platform for functionalization.  
Dendrimers 
Dendrimers are polymeric molecules composed of multiple perfectly 
branched monomers that emanate radially from the central core, 
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thus forming a tree-like structure. They consist of three critical 
architectural domains: (i) the multivalent surface, containing a larger 
number of potentially reactive sites, (ii) the interior shells (i.e., 
branch cell layers defined by dendrons) surrounding the core, and (iii) 
the core to which the dendrons are attached. These three domains 
can be tailored to serve various purposes, such as dendritic sensors, 
drug, contrast agent and gene carriers, or themselves as drugs. They 
have shown promise for biomedical applications because they (1) can 
be easily conjugated with targeting molecules, imaging agents, and 
drugs, (2) have high water solubility and well-defined chemical 
structures, (3) are biocompatible, and (4) are rapidly cleared from the 
blood through the kidneys, made possible by their small size (<5 nm), 
which eliminates the need for biodegradability. Furthermore the end 
groups of dendrimers can also be modulated to alter dendrimers’ 
solubility; for instance, the hydrophilic end groups can make a 
dendrimer with a hydrophobic core water soluble, whereas 
hydrophobic peripheral moieties can make a dendrimer with a 
hydrophilic interior soluble in oil. Although promising, dendrimers are 
more expensive than other nanoparticles and require many repetitive 
steps for synthesis, posing a challenge for large-scale production. 
Carbon nanotubes 
Carbon nanotubes (CNTs) consist exclusively of carbon atoms 
arranged in tubular structure. This novel artificial nanomaterial 
belongs to the family of fullerenes, the third allotropic form of 
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carbon . Based on the number of layers, structures of CNTs are 
classified into two types: single-walled carbon nanotubes (SWCNTs) 
and multiwalled carbon nanotubes (MWCNTs). SWCNTs consist of a 
single graphene cylinder with diameter varying between 0.4 and 
2 nm, and usually occur as hexagonal close-packed bundles. MWCNTs 
consist of two to several coaxial cylinders, each made of a single 
graphene sheet surrounding a hollow core. CNTs are not soluble in 
aqueous solutions because they have highly hydrophobic surfaces. 
Surface functionalization is required to solubilize CNTs, and to make 
them biocompatible and low toxic for their medical applications. 
They are being investigated as theranostic nanoparticles because of 
their tunable properties and ability to incorporate multiple 
functionalities. Many studies have confirmed CNTs to be effective 
carriers of therapeutics and imaging agent in vitro, however, in vivo 
studies have led to concerns regarding the associated toxicities. So, 
the primary barriers that must be overcome include route of 
biodegradation and reduction of off-target toxicity. 
Polymeric Nanoparticles 
Polymers are the most commonly explored materials for constructing 
nanoparticles-based drug carriers. Most polymeric nanoparticles are 
biodegradable and biocompatible, moreover, they exhibit a good 
potential for surface modification and functionalization with different 
ligands, provide excellent pharmacokinetic control and are suitable to 
encapsulate and deliver a plethora of therapeutic agents. The main 
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advantage of using polymeric nanoparticles for drug-delivery 
applications is their small size when taken up by cells, which could 
allow efficient drug accumulation at the target sites. Biodegradable 
materials used for their formulation allow sustained drug release 
within the target site over a period of days or even weeks. 
For preparation of nanoparticles is possible to use both natural 
hydrophilic polymer and synthetic hydrophobic polymer. Natural 
hydrophilic polymers such as proteins (gelatine, albumin, lecithin) 
and polysaccharides (alginate, dextran, chitosan) are widely used. But 
these polymers have certain disadvantages such as poor batch‑to‑
batch reproductivity, poor mechanical properties, limited residence 
time (fast degradation and absorption), and potential antigenicity. 
Synthetic hydrophobic polymers are characterized by low production 
costs, and it is possible to design them to obtain the desired 
chemical-physical properties. They are divided into two groups: The 
first group includes polyesters (poly (€‑caprolactone), poly(lactic 
acid), poly (lactide‑co‑glycolide), polystyrene) and the second group 
includes poly (alkyl cyanoacrylates) (poly (isobutyl cyanoacrylates), 
poly (butylcyanoacrylates), poly methyl (methcyanoacrylates)). 
Nanoparticles can be produced in two different approaches, by 
polymerization of the monomer or by the preformed polymer. The 
second case is preferable because the chemical/physical properties 
of the polymer are already well defined. Depending on the process 
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used for nanoparticles preparation, we can obtain nanospheres or 
nanocapsules.  
 
Figure 2: In this image the difference between nanoparticles and nanospheres as so 
between drug encapsulation and absorption is showed. 
Nanospheres are matrix particles, i.e., particles whose entire mass is 
solid and molecules may be adsorbed at the sphere surface or 
entrapped within the particle matrix. In general, they are spherical, 
but “nanospheres” with a nonspherical shape are also described in 
the literature. Nanocapsules are vesicular systems, acting as a kind of 
reservoir, in which the encapsulated substances are confined to a 
cavity consisting of a liquid core (either oil or water) surrounded by a 
solid material shell. 
PRODUCTION OF NANOCAPSULES: METHODS, ADVANTAGES 
AND DRAWBACKS 
Nanocapsules can be defined as nano-vesicular systems that exhibit a 
typical core-shell structure in which the drug is confined to a 
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reservoir or within a cavity surrounded by a polymer membrane or 
coating10. The cavity can contain the active substance in liquid or 
solid form or as a molecular dispersion. Likewise, this reservoir can 
be lipophilic or hydrophobic according to the preparation method 
and raw materials used. Also, taking into account the operative 
limitations of preparation methods, nanocapsules can also carry the 
active substance on their surfaces or imbibed in the polymeric 
membrane. 
Generally, there are six classical methods for the preparation of 
nanocapsules: nanoprecipitation, emulsion–diffusion, double 
emulsification, emulsion-coacervation, polymer-coating and layer-by-
layer. 
Nanoprecipitation (Solvent displacement) method 
The nanoprecipitation method is also called solvent displacement11. 
In this method, the nanocapsule synthesis needs both solvent and 
non-solvent phases. The solvent phase consists of a solution in a 
solvent or in a mixture of solvents (i.e. ethanol, acetone, hexane, 
methylene chloride or dioxane) of a film-forming substance such as a 
polymer (synthetic, semi-synthetic or naturally occurring polymer), 
the drug, oil and lipophilic surfactants. On the other hand, the non-
solvent phase consisting of a non-solvent or a mixture of non-
solvents for the film-forming substance, supplemented with one or 
more naturally occurring or synthetic surfactants. In most cases, the 
solvent and non-solvent phases are called organic and aqueous 
phases, respectively. As a general tendency, the solvent is an organic 
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medium, while the non-solvent is mainly water. However, it is 
possible to use either two organic phases or two aqueous phases as 
long as solubility, insolubility and miscibility conditions are satisfied. 
In the nanoprecipitation method, the nanocapsules are obtained as a 
colloidal suspension formed when the organic phase is added slowly 
and with moderate stirring to the aqueous phase.  
The key variables of the procedure are those associated with the 
conditions of adding the organic phase to the aqueous phase, such as 
organic phase injection rate, aqueous phase agitation rate, the 
method of organic phase addition and the organic phase/aqueous 
phase ratio. Likewise, nanocapsule characteristics are influenced by 
the nature and concentration of their components. Different theories 
have been developed to explain the mechanism of nanocapsules 
formation using this technique. The first is based on Sugimoto’s 
theory on polymer precipitation that indicated three stages for the 
process of particle formation in the nanoprecipitation: nucleation, 
growth and aggregation. The rate of each step determines the 
particle size and the driving force of these phenomena is 
supersaturation, which is defined as the ratio of polymer 
concentration over the solubility of the polymer in the solvent 
mixture. The separation between the nucleation and the growth 
stages is the key factor for uniform particle formation. Ideally, 
operating conditions should allow a high nucleation rate strongly 
dependent on supersaturation and low growth rate. The second 
theory is based on Gibbs–Marangoni effect, that explained rapid 
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nanoparticle formation as a process due to differences in surface 
tension, since a liquid with a high surface tension (aqueous phase) 
pulls more strongly on the surrounding liquid than one with a low 
surface tension (organic phase solvent). These differences between 
surface tensions cause interfacial turbulence and thermal inequalities 
in the system, leading to the continuous formation of eddies of 
solvent at the interface of both liquids. Consequently, violent 
spreading is observed due to mutual miscibility between the solvents, 
the solvent flows away from regions of low surface tension and the 
polymer tends to aggregate on the oil surface and forms 
nanocapsules. According to this explanation, nanocapsule formation 
is due to polymer aggregation in stabilized emulsion droplets, while 
apparently the nucleation and growth steps are not involved.  
Emulsion-diffusion method 
In emulsion-diffusion method12 the experimental procedure 
performed to achieve this requires three phases: organic, aqueous 
and dilution. In particular, the encapsulating polymer is dissolved in 
the organic phase that contain a partially water soluble solvent, 
saturated with water to ensure the initial thermodynamic equilibrium 
of both liquids, the active substance and oil. The aqueous phase is an 
aqueous dispersion of a stabilizing agent, prepared using water 
saturated with solvent, while the dilution phase is usually water. 
For preparation of nanocapsules using the emulsion–diffusion 
method, the organic phase is emulsified under vigorous agitation in 
the aqueous phase.  
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The subsequent addition of water to the system causes the diffusion 
of the solvent into the external phase, resulting in nanocapsule 
formation. This can be eliminated by distillation or cross-flow 
filtration depending on the boiling point of the solvent. It has been 
shown that nanocapsule size is related to the shear rate used in the 
emulsification process, the chemical composition of the organic 
phase, the polymer concentration, the oil-to-polymer ratio and the 
drop size of the primary emulsion.  The nanocapsule formation 
mechanism is based on the theory that each emulsion droplet 
produces several nanocapsules and that these are formed by the 
combination of polymer precipitation and interfacial phenomena 
during solvent diffusion. It is important to note that the interface 
between organic and aqueous phases was subjected to shear force 
during the emulsification step. Thus, for the emulsification–diffusion 
method it might be expected that surface tension gradients can be 
due to the thermal effects associated with heat transport during 
organic solvent diffusion. Typically, the thermal Marangoni effect 
results in fingering instability where the low interfacial tension 
difference and the drop curvature less than its spontaneous one 
allow that the flexible drop surface develops multiple undulations 
generating long fingers as the organic solvent diffuses towards the 
aqueous medium. In this process, the solvent carries polymer 
molecules into the aqueous phase. Then, if spontaneous curvature 
favors an organic phase-in water arrangement, it could be expected 
that many drops of smaller diameter detach from the fingers and 
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become dispersed in the aqueous phase. Thus new globules or 
polymer aggregates (not totally desolvated) are formed and 
stabilized by the stabilizing agent (protoparticles) which prevents 
their coalescence and the formation of agglomerates. The submicron 
particles will be formed after the complete diffusion of the solvent, if 
the stabilizing agent remains at the liquid–liquid interface during the 
diffusion process and if its protective effect is adequate. The mean 
nanocapsule size is always smaller than that of the emulsion droplets, 
in agreement with the diffusion theory proposed.  
This technique presents several advantages, such as high 
encapsulation efficiencies, no need for homogenization, high batch-
to-batch reproducibility, simplicity, and narrow size distribution. 
Disadvantages are the high volumes of water to be eliminated from 
the suspension and the leakage of water-soluble drug into the 
saturated-aqueous external phase during emulsification, reducing 
encapsulation efficiency.  
Double Emulsification 
Double emulsions13 are complex heterodisperse systems called 
“emulsions of emulsions”, that can be classified into two major types: 
water-oil-water emulsion (w/o/w) and oil-water-oil emulsion 
(o/w/o). Thus the dispersed phase is itself an emulsion and the inner 
dispersed globule/ droplet is separated from the outer liquid phase 
by a layer of another phase. Double emulsions are usually prepared 
in a two-step emulsification process using two surfactants: a 
hydrophobic one designed to stabilize the interface of the w/o 
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internal emulsion and a hydrophilic one to stabilize the external 
interface of the oil globules for w/o/w emulsions. For preparation of 
nanocapsules, the principle of double emulsion formation, 
specifically of the w/o/w type, is associated with the principles of 
both nanoprecipitation and emulsion–diffusion methods. In this case, 
in the primary w/o emulsion the oil is changed by an organic phase 
containing a solvent that is totally or partially miscible in water, the 
film-formed polymer and a w/o surfactant. Then the water 
containing a stabilizing agent is added to the system to obtain the 
water in organic in water emulsion. However in this step, particle 
hardening is obtained through solvent diffusion and polymer 
precipitation. Water is frequently added to the double emulsion in 
order to achieve full solvent diffusion. The surfactants play a dual role 
in emulsions: as a film former and a barrier to drug release at the 
internal interface, and as a steric stabilizer on the external interface. 
It was found that drug encapsulation efficiency and average particle 
size are affected by changing the type and concentration of both the 
w/o emulsion and the stabilizing agent. In a typical procedure for 
preparation of nanocapsules by double emulsification, the primary 
emulsion is formed by ultrasound and the w/o surfactant stabilizes 
the interface of the w/o internal emulsion. 
The second emulsion is also formed by ultrasound and nanocapsule 
dispersion is stabilized by the addition of the stabilizing agent. Finally, 
the solvents are removed by evaporation or extraction by vacuum, 
leaving hardened nanocapsules in an aqueous medium.  
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Emulsion-Coacervation method 
The emulsion-coacervation process is mainly presented as a strategy 
for nanocapsules preparation from naturally occurring polymeric 
materials. Up to now, sodium alginate and gelatin have been used 
though synthetic polymeric materials could be used for this purpose. 
The procedure involves the o/w emulsification of an organic phase 
(oil, active substance and active substance solvent if necessary) with 
an aqueous phase (water, polymer, stabilizing agent) by mechanical 
stirring or ultrasound. Then, a simple coacervation process is 
performed by using either electrolytes14, by the addition of a water 
miscible non-solvent15 or a dehydration agent or by temperature 
modification16. Finally, the coacervation process is complemented 
with additional crosslinked steps that make it possible to obtain a 
rigid nanocapsule shell structure. 
Nanocapsule formation by the emulsion-coacervation method uses 
the emulsion as a template phase and the formation of a coacervate 
phase that causes polymer precipitation from the continuous 
emulsion-phase to form a film on the template forming the 
nanocapsule. Additionally, it can be stabilized by physical 
intermolecular or covalent cross-linking, which typically can be 
achieved by altering pH or temperature, or by adding a cross-linking 
agent. Probably the critical stage in preparation of nanocapsules by 
the emulsion-coacervation method is coacervate phase formation17. 
In particular, the polymer dissolved in water is enclosed by water 
molecules that solvate its functional groups, typically through 
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hydrogen-bonding and van der Waals forces that prevent attraction 
among chain segments in close proximity by interchain H-bonds, or 
van der Waals or opposing ionic forces. Thus, the coacervating agents 
lower the solvation of dissolved polymers and induce thin solvated 
shell. It may also allow the attraction among contiguous chains via 
secondary valence bonds to form an entangled network or even non-
covalent weak cross-links as the polymer concentration gradually 
increases in the coacervated phase. The use of electrolytes for 
polymer desolvation is known as salting-out. On the other hand, in 
the case where a dehydrating agent is used, the ternary system 
formed (polymer – dehydrating agent– water) allows the increase of 
polymer concentration due to solvent–solvation competition process. 
This results in the desolvation of the polymer chains, leading to phase 
separation.  
Polymer Coating method 
In polymer coating method different methodological strategies can 
be used to deposit a thin layer of polymer on the nanoparticle 
surface. This can be achieved by adsorbing the polymer onto the 
preformed uncoated nanocapsules when the latter are incubated in 
polymer dispersion under predetermined stirring and time 
conditions18. Likewise, layer-formed polymer can be added during the 
final stage of conventional methods for the preparation of 
nanocapsules such as nanoprecipitation and double emulsification. 
Thus, these methods have been modified in order to add a layer of 
polymer to the external aqueous medium and allow to simultaneous 
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layer formation due to the precipitation of the charged polymer 
(mainly negatively in nature) and to the diffusion of the solvent. 
Another way is to prepare a nanoemulsion as template and then coat 
it by polymer deposition on the water/oil nanoemulsion surface. The 
polymers are added in the continuous phase and their precipitation 
onto the nanoemulsion droplets is triggered by solvent evaporation, 
as opposed to the emulsion coacervation method. For preparation of 
nanocapsules using this method an organic phase, composed of the 
active substance, oil, surfactant and solvent, and an aqueous phase 
containing the stabilizing agent and an aqueous polymer-coating 
solution are mixed under moderate stirring and the o/w 
nanoemulsion is formed by solvent displacement. The solvents are 
subsequently evaporated under vacuum until reaching a specific 
volume and the nanoemulsion is finally coated by the polymer by 
simple incubation in the polymer solution. The nanocapsule 
formation mechanism is mediated by the ionic interaction between 
surfactant and polymer.  
Layer-by-Layer method 
The layer-by-layer assembly process developed for colloidal particle 
preparation makes it possible to obtain vesicular particles, called 
polyelectrolyte capsules, with well-defined chemical and structural 
properties19. To sum up, the mechanism of nanocapsule formation is 
based on irreversible electrostatic attraction that leads to 
polyelectrolyte adsorption at supersaturating bulk polyelectrolyte 
concentrations. This method requires a colloidal template onto which 
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is adsorbed a polymer layer either by incubation in the polymer 
solution, subsequently washed, or by decreasing polymer solubility 
by drop-wise addition of a miscible solvent. This procedure is then 
repeated with a second polymer and multiple polymer layers are 
deposited sequentially, one after another. It can be used as a 
template the solid form of the active substance, as can inorganic 
particles and biological cells. Likewise, the adsorption of oppositely 
charged polyelectrolytes can be done on the surface of colloidal 
particles with subsequent core dissolution. Also emulsion droplets, 
prepared by high-pressure homogenization, can be used as template. 
Once the polyelectrolyte addition had ended, nanocapsule dispersion 
was again treated by high-pressure homogenization and the 
dispersion was finally centrifuged. The molecules employed for 
assembly should have a sufficient number of charged groups to 
provide stable adsorption on an oppositely charged surface and non-
compensated charges exposed to the exterior. Furthermore, this 
method raises other difficulties such as the formation of counterions 
aggregates, the separation of the remaining free polyelectrolyte from 
the particles prior to the next deposition cycle and polyelectrolyte-
induced bridging during centrifugation. Close particle–particle 
encounters may cause unfavorable interactions with the 
polyelectrolyte films, possibly leading to film destruction and 
aggregate formation. In addition, another difficulty is the particle 
sizes obtained which are higher than 500nm. Although these particle 
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sizes are at submicronic scale, they are obviously larger than the size 
commonly accepted for nanocapsules.  
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Thermally Induced Phase Separation (TIPS) 
As explained in the previous paragraphs, nanocapsules of desired 
shape, composition and with tailored properties have exhibited 
potential applications of wide scientific and technological interest in 
the field of nanomedicine. However, methods applied in 
nanocapsular structure productions are still limited by several 
drawbacks, related to their production, such as high polidispersity 
index, low biocompability, poor feasibility of scaling-up to produce 
the cost reduction required to target markets, and time consuming 
procedures not suitable to be industrialized. Thus, the aim of this 
work is to overcome limitations of methods currently proposed in the 
fabrication of nanocapsules through several novel approaches. 
In particular, most of the work involves Thermally Induced Phase 
Separation (TIPS) is a process based on the phenomenon that solvent 
effectiveness decreases when temperature is decreased20. Thus, 
when a homogeneous polymer solution at elevated temperature is 
cooled down, phase separation occurs, resulting in the formation of a 
polymer-rich phase and a polymer-lean phase. During the TIPS 
process the phase transitions may proceed in combinations with 
liquid–liquid phase separation and solidification such as vitrification, 
crystallization of the polymer, or freezing of the solvent. In most 
cases these solidifications are useful for fixing the structure of the 
solution at a certain stage during liquid–liquid phase separation. 
Afterwards, the solvent can be removed by evaporation, freeze 
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drying, and extraction with non-solvents or critical point drying. The 
final morphology of the solution is determined by the extent of the 
liquid–liquid phase separation before solidification. 
A typical phase diagram for a binary polymer solvent system is 
schematically represented in Fig . 
 
Figure 3: A schematic representation of a binary phase diagram of a polymer solution 
showing a liquid-liquid demixing gap. In addition, the possible structure formation in the 
different parts of the liquid-liquid demixing gap is indicated: nucleation  and growth of 
polymer rich phase (left picture), bicontinuous morphology due tospinodal decomposition 
(middle picture) and nucleation of a polymer poor phase (right picture). 
In the figure the temperature is plotted as function of the polymer 
concentration. At higher temperatures the solution is still 
homogeneous, at lower temperatures liquid-liquid phase separation 
can take place. The miscibility gap can be divided into three areas. 
The border of the miscibility gap is called the binodal, the dashed line 
is called the spinodal. Examples of compositions that are in 
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equilibrium are given by horizontal lines called tie lines. The point 
where the binodal and spinodal touch is called the critical point. At 
the critical point the polymer rich phase and the polymer poor phase 
have the same compositions. Compositions located between the 
binodal and the spinodal are metastable, this means that solutions 
are stable with respect to small composition fluctuations. However 
when the composition fluctuations are large enough phase 
separation will take place by nucleation and growth of a polymer 
poor phase in case the original composition of the solution is located 
at polymer concentrations lower than the critical point, resulting in a 
globular microporous structure. Likewise, the phase separation take 
place nucleation and growth of the polymer rich phase in case the 
polymer concentration is higher than the polymer concentration of 
the critical point, resulting in a cell-tunnel microporous structure. 
Solutions quenched into the area enclosed by the spinodal are 
unstable. Any composition fluctuation can trigger a wave of 
composition fluctuations through the solution. The amplitude of the 
fluctuations will increase because the molecules of both components 
will move from low concentration regions to high concentration 
regions. In this case demixing usually yields network structures, in 
which both the polymer rich phase and the polymer poor phase are 
completely interconnected, forming a continuous structure. The 
spinodal area can only be entered directly at the critical point. In all 
other cases, the metastable area must first be passed. High cooling 
rates can be used to prevent demixing in the metastable area. 
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Up to now, Thermally Induced Phase Separation has extensively been 
used to fabricate foams, membranes and various porous 
biodegradable scaffolds suitable for tissue engineering and drug 
delivery. Here in, we demonstrate that by performing TIPS within 
nanoconfinement21 a transition to semicrystalline vesicular 
morphology can be observed for the first time and the formation of 
the uniform nanocapsules with controllable size and shell thickness 
can be obtained. This kind of architecture presents crystal properties, 
important features in the design and behavior of biocompatible, 
biodegradable and functionalized vectors, opening the way to the 
role of surface crystallinity of nanocapsular structures on several 
physicochemical aspects of interaction with a biological system. In 
particular, for this purpose we focused our research on Poly-L-Lactic 
Acid (PLLA), because it is a biopolymer largely studied by TIPS22; 23, 
generally producing two main types of morphology: globular-like and 
membrane-like. In our case, a mixture of dioxane and water was used 
for a binary composition of solvent and antisolvent respectively of 
the polymer. In particular, the ternary system PLLA/Dioxane/Water is 
a well-known UCST (Upper Critical Solution Temperature) system, for 
which several cloud point studies have already been reported in 
literature. Its binodal-spinodal diagram shows that the fundamental 
condition to perform our experiment is at low polymer 
concentration, where a solvent rich phase formation, as well as 
globular-like morphology, is favorite by decreasing temperature.  
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AIM OF THE WORK 
 
In my PhD project I have focused my attention on Poly Lactic Acid  
because it is a synthetic polymeric material, already approved by The 
Food & Drug Administration on the basis of its good properties of 
non-toxicity, absolute biodegradability, adjustable degradation rate, 
and good biocompatibility24. In the first part of my work, I tried to 
take advantages by the Thermally Induced Phase Separation in order 
to control PLLA crystallization properties and to obtain for the first 
time nanocapsular morphology. Results were obtained by inducing 
phase transition of polymer chain in a nanoconfined domain. Later, I 
focused my attention on the tri-block copolymer made by PLA-PEG-
PLA and I studied their micellization behavior in order to encapsulate 
contrast agents for Enhanced MRI. Last efforts were devoted to the 
combining of the previous processes to obtain nanostructures for 
application in the theranostic field. We envision polymer 
nanocapsules with cancer drug entrapped within the core, protected 
by a soft shell made by triblock copolymer containing contrast 
agents. 
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 CHAPTER II: NANOCAPSULES PRODUCTION BY THERMALLY 
INDUCED PHASE SEPRATION IN A NANOCONFINEMENT 
INTRODUCTION 
Nanostructures were obtained through a novel approach based on 
Thermally Induced Phase Separation (TIPS) in nanoconfinement, that 
allows to obtain semicrystalline nanocapsules (down to 50 nm).Indeed, 
PLA is a slow-crystallizing material, and it is a hard challenge to succeed 
in inducing its crystallization in a TIPS process through the control of the 
main operating parameters. However, it is even more difficult to induce 
a nanoconfinement to produce semicrystalline PLLA nanocapsules by 
TIPS. Indeed, the prerequisites for a successful traditional TIPS process 
are (a) the complete miscibility between the liquid solvent and the 
antisolvent and (b) the insolubility of the solute in the antisolvent. So, in 
the approach that we are proposing, the idea was to follow the 
thermodynamic equilibrium of a standard ternary system with the 
peculiarity to induce the quenching phenomenon not in a macroscopic 
environment but in a single emulsion droplet, that we have called 
flexible nanoconfinement. For this purpose, we developed a new 
manufacturing process that takes advantages on the use of the 
innovative technology of High Pressure Homogenizer to produce very 
fine and more stable emulsions. Furthermore, this new process allows 
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producing stable, nanosized, biopolymer nanocapsules working in a 
continuous mode, with high throughput and in a cost effective way. 
MATERIALS  
Poly,L-lactic  acid (PLLA, Product name “ResomerTML 209 S”, with Mw = 
12.5 KDa), was purchased by Evonik Industries. 
Diethylene dioxide (1,4 – dioxane, anhydrous, purity 99.8%; density 
1,034 g/ml at 25°C (lit.); molecular formula 𝐶4𝐻8𝑂2; 𝑀𝑤 =
88,11 𝑔 𝑚𝑜𝑙−1), Polyvinyl alcohol (PVA, linear formula [-CH2CHOH-]n, 
 𝑀𝑤 = 13000 − 23000 𝑔 𝑚𝑜𝑙
−1), Pluronic F127 (PF127, powder, non-
ionic, cmc: 950-1000 ppm ), Rhodamine B (molecular formula 
𝐶28𝐻31𝐶𝑙𝑁2𝑂3;  𝑀𝑤 = 479.01 𝑔 𝑚𝑜𝑙
−1, powder, purity≥95% (HPLC)), 
Gadolinium (III) Chloride (anhydrous, powder, 99.99% trace metals 
basis), Threalose dehydrate (molecular formula 𝐶12𝐻22𝑂11 ∙ 2𝐻2𝑂; 
 𝑀𝑤 = 378.33 𝑔 𝑚𝑜𝑙
−1) were purchased by Sigma-Aldrich. Chromeo 
488 Carboxylic Acid (molecular formula 𝐶30𝐻31𝑁𝑂7;  𝑀𝑤 =
517.58 𝑔 𝑚𝑜𝑙−1, reagent color: yellow-orange) was purchased by Active 
Motif. 
The water, used as antisolvent for the polymer, was purified by 
distillation, deionization, and reserve osmosis (Milli–Q PLUS water 
purification system). 
Poly - Lactic Acid (PLA) 
Poly(lactic acid) (PLA) belongs to the family of aliphatic polyesters1; 2; 3. It 
can be produced by condensation polymerization directly from its basic 
building block lactic acid. The chiral nature of lactic acid results in 
43 
 
distinct forms of polylactide, namely, poly(L-lactide) (PLLA), poly(D-
lactide) (PDLA), and poly(DL-lactide) (PDLLA), which are synthesized 
from the L-, D-, and DL-lactic acid monomers, respectively. The 
polymerization of racemic (D,L)-lactide however, results in the 
formation of amorphous polymers. Commercial PLA is usually prepared 
from L-lactide (LLA), because the resulting poly(L-lactic acid) (PLLA) is 
semicrystalline (~ 37% crystallinity) with a relatively high melting (175°C) 
and glass transition temperature (Tg = 60-65°C). The monomer LLA can 
be prepared with relatively high enantiopurity from corn starch 
fermentation. PLLA is a versatile, degradable polymer having excellent 
mechanical properties, good biocompatibility, and low toxicity, and is 
FDA approved. It has been used in a variety of applications in the 
pharmaceutical and biomedical fields, as well as used as a degradable 
plastic for disposable consumer products. 
Processing, crystallization, and degradation behavior of PLA all depend 
on the structure and composition of the polymer chains, in particular on 
the ratio of the L- to the D-isomer of lactic acid4. PLLA is degraded by 
simple hydrolysis of the ester bond and does not require the presence 
of enzymes to catalyze this hydrolysis. 
METHODS 
PROTOCOL FOR PLLA NANOCAPSULES PRODUCTION 
Semicrystalline PLLA nanocapsules were produced in a cost effective 
and large quantity through an innovative Thermally Induced Phase 
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Separation (TIPS) approach starting by a preformed emulsion. Process 
has been performed in a continuous mode for preparing stable, 
dispensable, nanosized, biopolymer nanocapsules. A ternary solution of 
PLLA/water/Dioxane at a selected temperature ranging from 30 to 70°C 
was prepared. The components are added in an Erlenmeyer bulb, 
immersed in a silicone oil bath on a stirring hot plate, with a 
thermocouple used to control the oil bath temperature, set at 116°C, in 
order to allow the polymer to dissolve in the dioxane/water mixture. 
The system is maintained at this temperature for at least 3 hours 
(depending on the polymer concentration) in continuous stirring (300 – 
350 rpm), to facilitate the dissolution of the solid polymer pellets in 
solution and to keep the system homogeneity. The temperature of 
116°C is higher than both the boiling points of dioxane (101°C) and 
water (100°C), so, during the dissolution of the polymer, evaporation of 
the low molecular weight species is expected, with consequent 
undesired change in system composition. To avoid this drawback, a glass 
Liebig condenser is installed on the top of the Erlenmeyer bulb 
containing the solution allowing condensing the vapors generated from 
heating the system, restoring the desired solution composition. After 
several hours, when the solution appears transparent, without stopping 
stirring, the system temperature is finally lowered at the preferred 
temperature and maintained at this value for at least one hour before 
starting the experiment, in order to stabilize the homogeneous solution 
obtained. The preformed solution was added to a continuous phase 
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containing a selected surfactant at the same temperature, with a 
surfactant concentration ranging from 0,5 to 3wt%, as required. This 
pre-emulsion was treated by ultrasonication (Branson Sonifier 450 cell 
disruptor) for 5 minutes at constant Temperature, controlled by a 
thermocouple. Then, the pre-emulsion is directly flowed in the High 
Pressure Homogenizer (Microfluidics M110P) with a Pressure ranging 
from 1000 to 2000 bar. After recirculating the emulsion for 10 minutes 
at high shear rate, the cooling steps has been performed. The emulsion 
was unloaded and kept under stirring at the same temperature, then 
directly injected in a custom-made hydrodynamic flow focusing system 
obtained by cold water at 5-6 °C. Inlet and outlet temperature were 
measured by a thermocouple. The obtained capsules were kept at 7-8 °C 
for at least 15 minutes up to 30.  
 
Figure 1: Schematic representative of the process. 
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METHOD TO AVALUATE THE EFFECT OF COOLING RATE AND 
CONDITIONS ON THE SYSTEM 
In order to evaluate the influence of quenching step, different kind of 
cooling methods have been applied on polymer solution, on pre-
emulsion processed by ultrasonicator and on emulsion obtained by HPH, 
and different obtained morphologies have been observed. Protocols 
performed are listed below. 
 Polymer solution: 
o Method I. Cooling at room temperature 
Starting from the polymer solution at fixed polymer 
concentration, keeping ratio dioxane/water constantly at 87:13, 
cooling step has been performed by inducing the decreasing of 
the temperature leaving it at room temperature. The polymer 
solution temperature before the cooling step was always kept at 
80°C. 
o Method II. Cooling by water at room temperature 
Starting from the polymer solution at fixed polymer 
concentration, keeping ratio dioxane/water constantly at 87:13, 
cooling step has been performed by inducing the decreasing of 
the temperature leaving it at room temperature and then 
injecting it in water at room temperature. The polymer solution 
temperature before the cooling step was always kept at 80°C. 
o Method III. Cooling by cold water 
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Starting from the polymer solution at fixed polymer 
concentration, keeping ratio dioxane/water constantly at 87:13, 
cooling step has been performed by inducing the decreasing of 
the temperature injecting the solution in cold water. The 
polymer solution temperature before the cooling step was 
always kept at 80°C. 
o Method IV. Cooling at room temperature starting from 
different temperatures 
Starting from the polymer solution at fixed polymer 
concentration, keeping ratio dioxane/water constantly at 87:13, 
cooling step has been performed by inducing the decreasing of 
the temperature leaving it at room temperature, starting from 
different temperatures.  
 
 Pre-emulsion: 
o Method I. Cooling by liquid nitrogen bath 
Starting from the pre-emulsion at fixed polymer concentration, 
keeping ratio polymer/surfactant constantly at 1:2, cooling step 
has been performed by inducing the decreasing of the 
temperature immersing the pre-emulsion in a nitrogen bath. 
Temperature was monitored at the beginning and at the end. 
The pre-emulsion temperature before the injection was always 
kept at 80°C. 
o Method II. Cooling by by Flow focusing 
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Starting from the pre-emulsion at fixed polymer concentration, 
keeping ratio polymer/surfactant constantly at 1:2, a cooling 
step has been performed by a custom-made hydrodynamic flow 
focusing obtained by cold water at ~5°C. Temperature was 
monitored at the inlet and outlet of the system and the pre-
emulsion temperature before the injection was always kept at 
80°C. 
 
 Emulsion:  
o Method I. Cooling by Flow focusing 
Starting from our standard emulsion at fixed polymer 
concentration, keeping ratio polymer/surfactant constantly at 
1:2, a cooling step has been performed on by a custom-made 
hydrodynamic flow focusing obtained by cold water at ~5°C. 
Temperature was monitored at the inlet and outlet of the system 
and the emulsion temperature before the injection was always 
kept at 80°C. 
o Method II. Cooling by iced water jacket 
Starting from our standard emulsion at fixed polymer 
concentration, keeping ratio polymer/surfactant constantly at 
1:2, a cooling step has been performed by letting the emulsion 
through a silicon coil pipe covered with fine milled ice. 
Temperature was monitored at the inlet and outlet of the system 
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and the emulsion temperature before the injection was always 
kept at 80°C. 
o Method III. Cooling by liquid nitrogen vapors 
The same procedure as above was performed, with the 
difference that the silicon coil pipe is invested by liquid nitrogen 
vapors. Temperature was monitored at the inlet and outlet of 
the system and the emulsion temperature before the injection 
was always kept at 80°C. 
o Method IV. Cooling  by liquid nitrogen bath 
Starting from our standard emulsion at different polymer 
concentration, keeping ratio polymer/surfactant constantly at 
1:2, a cooling step has been performed by inducing the 
decreasing of the Temperature immersing the emulsion in a 
nitrogen bath. Temperature was monitored at the beginning and 
the end of the cooling. The emulsion temperature before the 
injection was always kept at 80°C.  
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MORPHOLOGICAL AND STRUCTURAL CHARACTERIZATION  
Nanocapsules characterization 
Hydrodynamic diameter, zeta potential, and polydispersity index of the 
PLLA nanoparticles are measured using a particle sizer (Nano-Zeta-sizer 
S90, Malvern Instruments, UK).In order to study their morphology, 
obtained nanocapsule’s suspension is often submitted to ultrafiltration 
under vacuum on a polycarbonate isopore membrane (cut-off 50 nm) to 
remove the residual water or surfactant. In a different purification step, 
the suspension isalso centrifuged at 55.000-80.000 rpm for 45 min 4°C 
by Ultracentrifuge Optima MAX-XP by Beckman Coulter. The 
morphology of the nanoparticles is observed under a Field Emission -
Scanning Electron Microscope (FE-SEM) Ultraplus Zeiss – EHT max 30 KV. 
To improve conductivity, SEM samples are indifferently coated with a 
thin layer of metal gold, chrome or platinum-palladium ranging from 3 
to 7 nm. 
The lyophilization of nanocapsules is performed using a freeze-dryer 
Christ, 1-4LSC. Briefly, a Freezing step for 3 h at 80°C with a cooling 
profile of 1°C/min is applied, sublimation at a shelf-temperature of 6° C 
and pressure of 0,85mbar for at least 24 h and finally, secondary drying 
at 25 °C and 0,03 mbar for 5-6 h. Trehalose or sucrose ranging from 1-
3wt% is added as cryoprotector if necessary. Dried particles are 
observed by Field Emission-SEM. 
The conventional transmission Electron Microscope (TEM) images are 
obtained at 80 and 200 kV with a FEI Tecnai 200T at a magnification 
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from 25 000 to 80.000 under low-dose conditions. Nanocapsular 
structures are also observed by CRYO-TEM under liquid Nitrogen and 
CRYO- Tomography on the same instrument. Cryo section of the 
instrument has been purchased by GATAN Inc. For cryo-TEM 
experiments in the TEM, commercially available lacey carbon 
membranes on 300-mesh copper grids are used. A sample of the dilute 
nanocapsule solution is applied to the grid, blotted to a thin film with 
filter paper, and immediately plunged into liquid propane/ethane (-186 
°C) using a vitrifrication system Vitrobot purchased by FEI. A Gatan 
model 626 cryo-transfer station and cryo-holder are used to transfer the 
grid containing the vitrified suspension into a TEM Tecnai FEI 200 kV. 
 
Calorimetric studies 
Thermal properties of PLLA semicrystalline NCs are studied by using 
differential scanning calorimetry (DSC) (TA Instruments) at a heating 
rate of 3-5 °C/min under nitrogen atmosphere. 
Glass transition temperature (Tg) is determined as the point of half Cp 
(heat capacity) extrapolated while the melting temperature (Tm) is 
determined as the peak temperature. The degree of crystallinity ( Xc ) of 
the PLLA nanocapsules is calculated as  
𝑋𝑐 =
𝛥𝐻𝑚
𝛥𝐻𝑚
0  
where 𝛥𝐻𝑚 is an enthalpy of melting of PLLA and 𝛥𝐻𝑚
0  is the enthalpy 
of melting of 100% crystalline PLLA. The melt enthalpy estimated for an 
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enantiopure PLA of 100% crystallinity (𝛥𝐻𝑚
0 ) is 93 J/g; it is the value 
most often referred to in the literature although higher values (up to 
148 J/g) also have been reported.  
X-ray diffraction studies 
X-ray diffraction data have been collected at room temperature from a 
PLLA nanocapsule’s suspension deposited onto Si zero-background 
substrates as well as from PLLA in powder. 
XRD measurements were performed with a D8 Discover-Bruker 
diffractometer equipped with a Cu source (λKα1= 1.54056 Å and λKα2= 
1.54439Å), a Goebel mirror, an Eurelian cradle goniometer, and a 
scintillator detector. XRD patterns were collected under ambient 
atmosphere at a fixed incident angle of 5° while moving the detector 
over the 10-60° range with a step size of 0.05. In this context we use X-
Ray diffraction to identify the crystalline/amorphous nature of PLLA 
nanocapsules and the extent of crystallinity present in the samples.  
The ratio between the integrated intensity  under the diffraction peaks 
(crystalline contribution) and the whole area under the entire XRD 
pattern (crystalline and amorphous contribution) was evaluated to 
determine the crystallinity degree. No additional background is present 
due to the zero contribution of the Si substrate. The results are reported 
in Figure 2 .  
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Figure 2: XRD pattern of PLLA powder. 
Fourier Transform Infrared Spectroscopy 
PLLA nanocapsules suspension is frozen in liquid nitrogen and then 
freeze dried to obtain a powder for IR measurements. PLLA powder for 
IR measurements is cast on a germanium window of a Nicolet 6700 FT-
IR Spectrometer. All the IR spectra of the specimen were collected at 
0.09 cm-1 resolution with 2 min interval.  
Several important papers have been published concerning the infrared 
spectra of PLA, and on structural changes and crystallization of PLLA. In 
some of these works, characteristic peaks of both amorphous and 
crystalline phase of PLLA were obtained. In particular, among the 
crystalline sensitive bands, the 1458 cm-1 band has been assigned to the 
structural order of the CH3 group, while the band at 1109 cm
-1 relates to 
the C-O-C trans conformation in the crystalline phase of PLLA. In 
addition, the band at 1193 cm-1 is sensitive not only to the structural 
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adjustment of C-O-C but also to the structural order of CH3 group in the 
crystalline phase. Moreover the 1762 cm-1 band has been assigned to 
the ν(C=O) in the crystalline phase and the 1749 cm-1 band to the ν(C=O) 
in the amorphous phase. In literature have been reported also two 
bands that are related to the crystalline and the amorphous phase of 
PLA, at 755 cm-1 and 869 cm-1 respectively5, and the band at 923 cm-1, 
that was found in all the samples containing α crystals, assigned to the 
coupling of C-C backbone stretching with the CH3 rocking mode, and the 
band at 912 cm-1, assigned to the CH3 rocking mode for β crystals
6. 
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Figure 3: IR spectrum  of PLLA and PLLA NCs, plotted as transmission. 
Estimation of Drug Content 
10 milligrams of drug-loaded nanoparticles of each batch are dispersed 
in 1 ml of water and 200 microliter of Dichloromethane (DCM). After 
DCM evaporation, next the resultant solution is centrifuged, the 
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supernatant liquid is collected, and the absorbance is determined using 
an ultraviolet (UV) spectrophotometer at 556 nm, with water as a blank. 
Drug content in the nanoparticles is calculated using the following 
formula: 
In Vitro Drug Release Studies 
Drug content (%w/w)(Mass of drug in nanocapsules / Mass of 
nanoparticles) X 100,  : The dialysis bag diffusion technique was used to 
study the in vitro drug release of nanoparticles. The prepared 
nanoparticles were placed in the dialysis bag and immersed into 50 ml 
of Phosphate buffer pH (7.4). The entire system was kept at 37±0.5°C, 
with continuous magnetic stirring. The samples were withdrawn from 
the receptor compartment at predetermined intervals of 30 minutes 
and replaced by fresh medium. The samples were withdrawn and 
diluted to 10 ml with Phosphate buffer pH (7.4) and the amount of drug 
dissolved was analyzed by a UV-Spectrophotometer. All experiments 
were repeated in triplicate. When metal compounds were encapsulated, 
loading capability was measured for than measure by Induced Coupled 
Plasma-Mass (ICP-MS NexIon 300 by Perkin Elmer). 
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RESULTS 
 
 
Figure 4: Flow sheet of the steps performed to produce nanocapsules by TIPS in a 
nanoconfinement. 
 
 
 
 
 
OPTIMIZATION OF ULTRASONICATION PARAMETERS 
As showed in Figure 4, the first step to be performed in our process is 
the ultrasonication. Optimization of the ultrasonication conditions 
needed before proceedings with the next steps.  Stability, size, 
surfactant concentration and time of sonication as well as Amplitude 
have been studied. Table 1 shows all the data related to this 
optimization. 
Temp 
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Ultrasonicator  Time of 
Homogenization 
Pre-emulsion 
Temperature 
DLS 
 
Amplitude Time (min) TEMPERATURE 
(°C) 
Size 
(nm) 
PDI 
20% 5,10,15* 30 800,7 0,910 
40% 5,10,15* 40 338,7 0,798 
60% 5,10,15* 65 218,4 0,77 
Table1: Optimization of ultrasonication parameters. *Data obtained at 10 
and 15 minutes haven’t been reported because in all cases a strong solvent 
evaporation was observed. 
 
This table reports only some conditions of the pre-emulsion used to 
obtain the nanocapsules. Several parameters were tested such as 
Amplitude and Ultrasonication time, in addition surfactant 
concentration were also studied. However, only in some cases has been 
possible to reach the desired Temperature and the desired droplet size 
(nanoconfined domain) and in no case has been possible to obtain the 
nanocapsules without the High Pressure Homogenization. 
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Figure 5: SEM Image of morphology obtained by TIPS performed only after the ultrasonication 
without High Pressure Homogenization 
EFFECT OF HIGH PRESSURE HOMOGENIZATION 
Ours experimental results showed that nanocapsular hollow 
semicrystalline PLLA structures are only obtained when the mean 
droplet diameter of the primary emulsion is below 500 nm with a 
polydispersity index measured by DLS of about 0.15. In contrast, when 
the mean droplet diameter of the primary emulsion is higher than 500 
nm, not-hollow nanoparticles are obtained. Thus, a High Pressure 
Homogenizer (HPH, Microfluidics M110P) has been employed, because 
it is particularly suitable for the production of the finely dispersed 
emulsion that we want to realize. To demonstrate that passing from 
Ultrasonication to High Pressure Homogenizer we attain a finer 
emulsion we carried out measurements by DLS on nanocapsules 
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suspension, at a fixed formulation of emulsion (in terms of 
concentration of polymer, concentration of surfactant and ratio 
discontinuous phase/continuous phase).The results achieved are shown 
in the Figure 6a, in which we can observe the reduction of mean droplet 
size of emulsion. Therefore, we reported also experiments conducted on 
emulsion optimization, by tuning HPH parameters, like homogenization 
time (number of passes) and pressure, and emulsion formulation. In 
particular, in Figure 6b is shown the optimization of homogenization 
time, from which we can derive that by increasing the number of passes 
of the whole emulsion volume inside the homogenizer valve, we can 
obtain a further decreasing of emulsion droplet size, and that the 
optimal number of passes corresponds to the point at which the plateau 
is reached. 
 
Figure 6: Size Measurement by DLS of emulsion droplet size, a) size reduction obtained by 
passing from Ultrasonication to High pressure homogenization; b) size reduction obtained by 
increasing number of passes in the homogenizer valve. 
Afterwards, we have evaluated the influence of homogenization 
pressure on emulsion mean droplet diameter. The results are reported 
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in the following Figure 7, where we can observe that the emulsion 
droplet size decrease when homogenization pressure increase. This is 
completely in agreement with theories on Microfluidizer reported in 
literature, that correlate the emulsion droplet size with the energy 
required for droplets disruption  
𝑥 = 𝐶 · 𝐸𝑉
−𝑏 = 𝐶·(𝑃𝑉 ·  𝑡𝑟𝑒𝑠  )
−𝑏 = 𝐶·(𝛥𝑝𝐻 )
−𝑏 
 that corresponds to the pressure difference operating at the nozzle. 
 
Figure 7: Size Measurement by DLS of emulsion droplet size as function of homogenization 
pressure. 
Another important point on which we can play for emulsion 
optimization is its formulation. Thus, we carried out tests by changing 
the concentration of surfactant and the type of surfactant in the 
continuous phase of emulsion. The results obtained are reported in the 
following Figure 8, where we can observe that emulsion droplet size 
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decrease when surfactant concentration increase, in agreement with 
the theory on Microfluidizer reported in literature, that correlate the 
emulsion droplet size with viscosity of continuous phase 
𝑥 = 𝐶·𝜂𝑐
𝑏 = 𝐶·𝜂𝑐
−0.02 
that increase when surfactant concentration increase. 
 
Figure 8: Size Measurement by DLS of emulsion droplet size as function of surfactant 
concentration and of kind of surfactant. 
Moreover, we can also observe that better results are obtained with 
Pluronic F127. 
EFFECT OF COOLING RATE ON THE FINAL MORPHLOGY 
In order to evaluate the influence of cooling on the final morphology of 
our nanocapsules we performed different kind of experiments on 
polymer solution, pre-emulsion processed by ultrasonicator and 
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emulsion obtained by HPH, by changing the cooling method and rate. 
The results obtained for each case are presented below. 
Polymer solution: 
 Method I. Cooling at room temperature 
The polymer solution at 80°C has been cooled by leaving it at room 
temperature, in order to simulate a slow cooling rate. The result is 
showed in the following Figure 9. Because of lack in temperature control 
the system is subjected to local fluctuation, resulting in the formation of 
both globular (a and c) and bicontinuous (b) morphologies, as showed in 
the following SEM images. 
 
Figure 9: : Electron Microscope images showing the morphology obtained by cooling polymer 
solution (with 0.5% of PLLA in Dioxane/ H2O=87/13) at room temperature.Because of lack in 
temperature control the system is subjected to local fluctuation, resulting in the formation of 
both globular (a and c) and bicontinuous (b) morphologies. 
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 Method II. Cooling by water at room temperature 
The polymer solution at 80°C has been cooled by leaving it at room 
temperature and then injecting it in water at room temperature, in 
order to evaluate not only the effect of a slow cooling rate but also that 
of extraction of dioxane in water. The result is showed in the following 
Figure 10. In this case, from SEM images (a and b) can observe the 
formation of globular morphologies fused together. 
 
Figure 10: : Electron Microscope images showing the morphology obtained by cooling polymer 
solution (with 0.5% of PLLA in Dioxane/ H2O=87/13) at room temperature and injecting it in 
water at the same temperature. Both images (a and b) show the formation of globular 
morphologies fused together. 
 Method III. Cooling by cold water 
The polymer solution at 80°C has been cooled by injecting it in cold 
water, in order to simulate a fast cooling rate. The result is showed in 
the following Figure 11. From SEM images (a and b) we can observe the 
formation of globular morphologies. 
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Figure 11: Electron Microscope images showing the morphology obtained by cooling polymer 
solution (with 0.5% of PLLA in Dioxane/ H2O=87/13)by injection in cold water. Both images (a 
and b) show the formation of globular morphologies. 
 Method IV. Cooling at room temperature starting from 
different temperatures 
The polymer solution has been cooled starting from different 
temperatures (80, 35, 30, 25, 15°C) by leaving it at room temperature, in 
order to evaluate not only the effect of a slow cooling rate but also that 
of different quench dept. The result is showed in the following Figure 
12. In particular, we can observe from SEM images the formation of: an 
homogeneous polymer layer starting from a polymer solution at 80°C 
(a); connected polymer branches starting from a polymer solution at 
35°C (b); connected polymer branches and globular morphologies 
starting from a polymer solution at 30°C(c); polymer branches and 
globular morphologies starting from a polymer solution at 25°C (d); 
globular morphologies starting from a polymer solution at 15°C (e). 
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Figure 12: Electron Microscope images showing the morphology obtained by cooling polymer 
solution (with 0.5%of PLLA in Dioxane/ H2O=87/13) at room temperature, starting from 
different initial temperatures. We observe: at 80°C (a) an homogeneous polymer layer;  at 35°c 
(b) connected polymer branches; at 30°C (c) connected polymer branches and globular 
morphologies; (d) at 25°C polymer  branches and globular morphologies; (e) at 15°C globular 
morphologies. 
Pre-emulsion: 
 Method I. Cooling by liquid nitrogen bath 
The pre-emulsion at 80°C, obtained by Ultrasonication, has been cooled 
by immersing it in a nitrogen bath, in order to evaluate the effect of fast 
cooling rate. The result is showed in the following Figure 13. From SEM 
images we can observe the formation of slices of polymer (a) and (b) 
globular morphologies.  
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Figure 13: Electron Microscope images showing the morphology obtained by cooling pre-
emulsion (with Polymeric solution: 1% of PLLA in Dioxane/ H2O=87/13; Continuous phase: 
3.5% of PF127 in H2O) in a liquid nitrogen bath. We observe the presence of slices of polymer 
(a) and (b) globular morphologies. 
 Method II. Cooling by Flow focusing 
The pre-emulsion at 80°C, obtained by Ultrasonication, has been cooled 
by a custom-made hydrodynamic flow focusing obtained by cold water 
at ~5°C, in order to evaluate the effect of a cooling rate slower than the 
previous method, but still fast, and to obtain a more controlled cooling. 
The result is showed in the following Figure 14. From SEM images (a and 
b) we can observe the formation of well-defined micro and 
nanoparticles. 
 
Figure 14: morphology obtained by cooling pre-emulsion (with Polymeric solution: 1% of PLLA 
in Dioxane/ H2O=87/13; Continuous phase: 3.5% of PF127 in H2O) in a liquid nitrogen bath. In 
both images (a and b) we observe well defined micro and nanoparticles. 
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Emulsion:  
 Method I. Cooling by iced water jacket 
The emulsion at 80°C, obtained by High Pressure Homogenization, has 
been cooled by letting it through a silicon coil pipe covered with fine 
milled ice, in order to evaluate the effect of a medium fast cooling rate. 
The result is showed in the following Figure 15. From SEM images (a and 
b) we can observe the formation of well-defined micro and 
nanoparticles. 
 
Figure 15: Electron Microscope images showing the morphology obtained by cooling the 
emulsion (with Polymeric solution: 0.5% of PLLA in Dioxane/ H2O=87/13; Continuous phase: 
1% of PVA in H2O), processed in HPH, letting through a silicon pipe coil covered with fine 
milled ice. In both images (a and b) we observe well defined micro and nanoparticles. 
 Method II. Cooling by liquid nitrogen vapors 
The same procedure as above was performed, with the difference that 
the silicon coil pipe is invested by liquid nitrogen vapors, in order to 
evaluate the effect of a medium fast cooling rate. The result is showed 
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in the following Figure 16.From SEM images (a and b) we can observe 
the formation of well-defined micro and nanoparticles. 
 
Figure 16: Electron Microscope images showing the morphology obtained letting the emulsion 
(with Polymeric solution: 0.5% of PLLA in Dioxane/ H2O=87/13; Continuous phase: 1% of PVA 
in H2O), processed in HPH, in a silicon pipe coil  cooled by liquid nitrogen fumes. In both 
images (a and b) we observe well defined micro and nanoparticles. 
 Method III. Cooling  by liquid nitrogen bath 
The emulsion at 80°C, obtained by High Pressure Homogenization, has 
been cooled by immersing it in a nitrogen bath, in order to evaluate the 
effect of a fast cooling rate. The result is showed in the following Figure 
17. From SEM images (a and b) we can observe the formation of well-
defined micro and nanoparticles. 
 
Figure 17: Electron Microscope images showing the morphology obtained by immerging the 
emulsion (with Polymeric solution: 0.5% of PLLA in Dioxane/ H2O=87/13; Continuous phase: 
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1% of PVA in H2O), processed by HPH, in a liquid nitrogen bath. In both images (a and b) we 
observe well defined micro and nanoparticles. 
 Method IV. Cooling by Flow focusing 
The emulsion at 80°C, obtained by High Pressure Homogenization, has 
been cooled by a custom-made hydrodynamic flow focusing obtained by 
cold water at ~5°C, in order evaluate the effect of a medium fast cooling 
rate and to obtain a more controlled cooling. The result is showed in the 
following Figure 18. SEM images (a and b) we can observe the formation 
of well-defined nanoparticles. 
 
 
Figure 18: Electron Microscope images showing the morphology obtained by cooling the 
emulsion (with Polymeric solution: 0.5% of PLLA in Dioxane/ H2O=87/13; Continuous phase: 
1% of PVA in H2O), processed by HPH, by flow focusing. In both images (a and b) we observe 
well defined nanoparticles. 
PURIFICATION AND RECOVERY 
ULTRAFILTRATION 
Vacuum filtration was used to collect nanocapsules for a better 
characterization by SEM. Indeed, SEM characterization could be done on 
a droplet of nanocapsules suspension, left to dry on a glass. In this way, 
however, we would get an unclear image because of the impurities 
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present in the system. Vacuum filtration allows to come away 
impurities, leaving almost cleaned nanocapsules on the surface of the 
membrane, as can be seen in the following Figure 19. 
 
Figure 19: Collection of nanocapsules by Ultrafiltration: a, SEM image of dried nanocapsules on 
a glass; b, SEM image of nanocapsules collected by Ultrafiltration on a membrane. 
MEMBRANE DYALISIS METHOD 
In this work, this technique has been employed to remove the excess of 
dye used in loading tests and to purify nanocapsule suspension from 
surfactant present in the formulation for the production. In the first 
case, to assess cleaning of the suspension, we carried out 
spectrofluorimetric tests. Indeed, in the second case, to prove the 
purification, we made IR measurements, on the suspension before and 
after the dialysis, as reported in the following images.  
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Figure20: Purification of nanocapsules by Membrane Dialysis method: a, IR measurement on 
dried nanocapsules before dialysis; b, IR measurement on dried nanocapsules after dalysis. 
 As we can see from Figure 20, before dialysis the IR spectrum of 
surfactant completely cover that one of PLLA nanocapsules, whereas the 
latter results more evident after the purification. 
ULTRACENTRIFUGE 
Ultracentrifuge has been employed, at first, to collect produced 
nanocapsules from our suspension. As can be seen in the following 
image (Figure 21), the protocol developed for this purpose was found to 
be effective, as nanocapsules are present for almost the totality in the 
pellet. 
 
Figure 21: Collection of nanocapsules by Ultracentrifuge: a, SEM image of nanocapsules 
collected in the pellet by Ultracentrifuge; b SEM image of nanocapsules collected in the 
supernatant by Ultracentrifuge. 
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Moreover, this technique has also allowed us to purify nanocapsules 
from surfactant present in the formulation for the production. To prove 
this, we carried out IR measurements on supernatant and on pellet 
obtained after the Ultracentrifuge, which shows also this result, as 
reported in Figure 22.  
 
Figure 22: Purification of nanocapsules by Ultracentrifuge: a, IR measurement of nanocapsules 
collected in the pellet by Ultracentrifuge; b IR measurement of nanocapsules collected in the 
supernatant by Ultracentrifuge. 
FREEZE DRYING 
Freeze-drying has been used to completely remove water from the 
frozen nanocapsules suspension by sublimation and desorption under 
vacuum. Generally, protectants are added to the formulation to protect 
the nanoparticles from freezing and desiccation stresses. In particular, 
for our nanocapsules trehalose as cryo-protectant was used, with a ratio 
1:1, because in literature has been reported to be a preferable cryo-
protectant for biomolecules. It has many advantages in comparison with 
the other sugars as: less hygroscopicity, an absence of internal hydrogen 
bounds which allows more flexible formation of hydrogen bonds with 
nanoparticles during freeze-drying, very low chemical reactivity and 
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finally, higher glass transition temperature. The results are noticeable, 
as reported in the following Figure 23 which show clearly that without 
the cryo-protectant nanocapsules tend to merge with each other, while 
using trehalose they retain their structure downstream the process. 
 
Figure 23: Freeze Drying of nanocapsules: a, SEM image of freeze-dried nanocapsules without 
cryo-protectant ; b SEM image of freeze-dried nanocapsules with Trehalose. 
MORPHOLOGICAL CHARACTERIZATION OF NANOCAPSULES 
The production of semicrystalline PLLA nanocapsules was attained 
modifying a standard TIPS process, in order to control the extent of PLLA 
crystallization. In particular, the production process consists in the 
preparation through High pressure homogenization of a primary 
emulsion, where the disperse phase is a ternary system 
polymer/solvent/antisolvent, whereas the continuous phase is made by 
an aqueous solution containing a high concentration of surfactant. PLLA 
phase separation is induced by cooling the emulsion by cold water at 
5°C, which cause the rapid decrease of the emulsion temperature from 
5 to 9°C on dependence of the cooling flow rate. In Figure 24a, Scanning 
Electron Microscope (SEM) images of the produced nanoparticles 
obtained at 2000 bar and PLLA concentration of 0.1 wt/v% with a mean 
74 
 
particle diameter of 70 nm are shown whereas the data of their mean 
particle size are reported in Figure 24b as a function of the main 
operating conditions (pressure, polymer concentration, temperature 
and homogenization time). 
In particular, polymer concentration, as so pressure and homogenization 
time, significantly influence the droplet size distribution of the primary 
emulsion and therefore the formation of hollow capsules (Figure 24c) as 
well as the regulation of their size and shell thickness. More specifically, 
experimental results clearly showed that by reducing the polymer 
concentration from 1.5 to 0.1 %wt/v a decreasing in nanocapsules mean 
diameter and standard deviation is obtained. 
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Figure 24: Size and Shape of PLLA Semicrystalline Nanocapsules by SEM and DLS results. a, 
Scanning Electron Microscope images showing the morphology of Nanocapsules obtained by 
TIPS (PLLA NCs Mean Diameter: 70 nm); b, Table reporting details about the conducted 
experimental campaign and the related mean diameter. Last columns within the table show 
Standard Deviation (SD) and Polydispersity Index (PDI) as obtained by Dynamic Light 
Scattering results. All the experiments have been performed at same conditions of 
Temperature and cooling rate; c, the effect of polymer concentration on the mean diameter is 
plotted on the graph; d, Detail of a Particle Size Distribution obtained for experiments 
conducted at 2000 bar and PLLA concentration of 0,5% wt/v. 
The hollow structure of the produced nanocapsules is evident from 
Transmission Electron Microscopy (TEM) images, shown in Figure 25. In 
particular, Figure 25a shows the nanocaspules formation for a low PLLA 
concentration (1%wt/v). Figures 25b instead shows that an increase in 
PLLA concentration (1.5%wt/v) causes an increase in capsule size. Figure 
25c shows an enlargement of the semi-crystalline nanocapsule, 
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highlighting the organization between crystalline phase and amorphous 
phase. 
 
Figure 25: Analysis of shell thickness by TEM results. a-c, Cryo –TEM and TEM nanocapsules 
obtained by Thermally Induced Phase Separation in a nanoconfinement by changing the 
polymer concentration from 0,5 to 1,5wt%, respectively; d, Graph showing the reduction of 
shell thickness as a function of the NCs mean diameter 
Figure 25d reports the dependence of shell thickness, evaluated from 
TEM images, on the mean particle size of the hollow capsules, the latter 
derived from DLS measurements. As it is possible to observe, the 
reduction in polymer concentration in the disperse phase of the primary 
emulsion causes a decrease of size as well as of shell thickness of the 
produced nanocapsules. Reported results are obtained at constant 
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pressure and homogenization time. Related to their mean diameter, the 
produced semi-crystalline PLLA nanocapsules (NCs) exhibited a shell 
thickness of maximum 32 nm. The release mechanism is also modified 
by this interesting morphology.  
Shell thickness of nanocapsules should dictate the mechanical strength 
and the permeability of the shell even if these peculiar characteristic 
required further investigations. However, even if the observed shell 
thickness of the produced NCs is relatively low, they, because of their 
semi-crystalline nature, should exhibit a compact structure with a low 
permeability value not reported until now in capsules with thinner 
shell7; 8; 9. 
CRYSTALLINITY BEHAVIOR OF THE PRODUCED NANOCAPSULES 
Among commercial biopolymers, poly-L-lactic acid (PLLA) exhibits 
adequate characteristics in terms of crystal polymorphism due to a 
chiral center in its molecular structure. Despite extensive studies, its 
crystallization behavior, crystal structure, and melting behavior are still 
not completely understood. For all these reasons, PLLA crystallization 
from a solution in a nanoconfined environment, compared to that in a 
macroscopic one, offers the potential to control the crystallization 
degree and to reduce time of crystal formation process, thus extending 
its range of applications, especially in biomedical and pharmaceutical 
devices by designing new polymer architectures and expanding their 
industrial utilizations.  
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To date, three crystalline forms (α, β, and γ) have been reported for 
PLLA upon changing the preparation conditions6; 10; 11; 12. Crystallization 
from the melt or from solution leads to α crystal form, which is the most 
common polymorph. In α form, two antiparallel chains with a left-
handed 103 helical conformation are packed into an orthorhombic unit 
cell with dimensions of a=10.7 Å, b=6.45 Å, and c=27.8 Å (along fiber 
axis). The β form is obtained by hot drawing the melt-spun or solution-
spun PLLA fibers under high drawing conditions and high drawing 
temperatures and it is considered to have a frustrated structure, 
containing three 31 helix chains in a trigonal unit cell with a=b=10.52 Å 
and c=8.8 Å. This frustrated structure appears to be formed to 
accommodate the random orientation of neighboring chains associated 
with the rapid crystallization during stretching. As for the transition 
between α- and β-crystalline phases, it was found that α-to-β crystalline 
phase transition in PLLA proceeded more rapidly with an increase in the 
draw ratio, draw temperature or extrusion pressure. The α-structure 
with a Tm of 185°C is more stable than the β-structure with a Tm of 
175°C1. A new crystal modification, γ form, has been recently observed 
via epitaxial crystallization on hexamethylbenzene (HMB) substrate. Two 
antiparallel helices were packed in an orthorhombic unit cell of 
parameters a=0.995 nm, b=0.625 nm, and c=0.880 nm. HMB appeared 
to be a versatile substrate, but the detailed mechanism of formation 
and thermal properties of the γ -form crystals are yet to be 
determined13.  
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Crystallinity changes of semi-crystalline PLLA depend not only on the 
preparation conditions, but also on the cooling rate, as generally 
observed by DSC analysis. Typically in TIPS processes, as well as in 
injection molding, the crystalline phase of PLLA is only obtained at low 
cooling rate14. In contrast, at high cooling rate, amorphous products are 
formed15. Instead, in the approach that we have developed, a 
semicrystalline morphology is obtained at very high cooling rates, in 
excess of 40°C/min, proving that a different phenomenon is interfering 
with the thermodynamic involved in the nanocapsules formation.  
The DSC curves obtained for the produced nanocapsules are showed in 
Figure 26a, whereas the thermal results are listed in Figure 26b. The 
average glass transition temperature (Tg) of PLLA NCs ranged from about 
50°C to 55°C and different Tm peaks are showed by changing 
experimental parameters. More specifically, Figure 26a shows the 
melting behavior of untreated raw PLLA in comparison with the PLLA 
nanocapsules produced by nanoconfined TIPS. The raw PLLA DSC curves 
exhibit a single and sharp melting peak at 183.9 °C, whereas dried PLLA 
nanocapsules, obtained at different processing conditions, always 
exhibit a complex melting behavior, with multiple endothermic peaks at 
different temperatures. In details, two endothermic peaks appear in the 
DSC curve of NCs at 0.1%wt/v (red curve in Figure 26a), which can be 
assigned as low and high melting temperatures (respectively, L and H in 
Figure 26a). At increasing polymer concentration, the peak at low 
melting temperature and its peak area decrease, whereas the peaks at 
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high temperature increase gradually up to temperatures higher than 
those usually observed for PLLA concentration of 1.5 %wt/v. The low (L)- 
and high (H) -temperature endothermic peaks appear when the rate of 
melting overwhelms that of the recrystallization.  
A double melting peak is a common phenomenon for polymers and can 
drive to different interpretations. It can be due to the presence of two 
distinct crystal forms or morphological structures in the original sample, 
but often, it is the results of annealing occurring during DSC scans 
whereby less perfect crystals have time to recrystallize a few degrees 
above and to remelt16; 17; 18. This so called melt-recrystallization model 
suggests that the low-temperature and high-temperature peaks in the 
DSC melting curve are attributed to the melting of some amount of 
original crystals and as well as to the melting of crystals formed through 
the melt-recrystallization process during a heating scan. Then, the 
exothermic dip between the two endothermic peaks is attributed to 
recrystallization. That is, the melting proceeds through the process of 
the melting of original crystals, and then to recrystallization and melting 
of recrystallized and perfected crystals.  
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Figure 26: Crystallinity grade analysis by DSC and XRD. a, DSC heating curves of PLLA 
nanocapsules at different polymer concentration, from the top: 0,1- 0,5- 1- 1,5 %wt/v – PLLA 
Raw; b, Table reports DSC data in detail and the crystallinity grade, showing how the polymer 
concentration can influence crystallization phenomena (DSC heating rate: 5°C/min); c,  XRD 
patterns at different PLLA concentration from 0.1 wt/v % to 1.5wt/v%; d, degree of 
crystallinity versus PLLA concentration. 
Indeed, the melt-recrystallization model suggests that small and/or 
imperfect crystals change successively to more stable crystals through 
melt-recrystallization process leading to a competitive process between 
melting and recrystallization.  
In addition, another model reported to explain this crystallization 
behavior is dual lamellae population model19. In particular, lamellar 
structures, due to the melting procedure and polymeric material, can 
range from hundred angstroms to several hundred of angstroms and the 
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extreme thinness of these lamellar crystals causes their melting point to 
be depressed below the typical melting temperature. In particular, 
samples that are crystallized by quenching or slow cooling from melt to 
room temperature will have crystallized to a considerable extent at high 
degree of undercooling from their typical melting temperature. Since 
crystallization at low growth temperatures produces very thin lamellae, 
such samples contain large fraction of low melting crystals that cause 
melting depression.  
However, even if these observations have been reported for 
crystallization from a melted polymer they could be considered valid, 
taking into account the intrinsic differences existing for our 
nanocapsular system obtained by cooling a polymeric solution. The 
overall results hence suggest that the TIPS process can be dramatically 
modified in a nanoconfined system up to induce crystallization. Indeed, 
in our system, differently from conventional TIPS processes, 
crystallization appears to be controlled not only by cooling rate but also 
by the presence of the antisolvent and of the geometrical 
nanoconfinement due to constrain of the polymer within the primary 
emulsion droplets, both energetically reducing the mobility of the 
polymer and increasing polymer-polymer interactions in solution. Thus, 
this evidence shows that by inducing TIPS of a selected ternary solution 
within a nanoconfinement, the formation of the polymer chain can still 
occur leading to a high crystallization behavior and, in some cases, to a 
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less stable α crystal or thinner lamellae, compared to those obtained by 
traditional TIPS.  
A further confirmation that the crystallization phenomenon is induced 
by the polymer nanoconfinement in the primary emulsion droplet can 
be derived when considering the behavior previously observed in 
twisted and curved crystals and to the different interpretations 
proposed.  Indeed, our results clearly show the curved shape of the 
nanocapsular shell, presuming the coexistence of curved crystals within 
the shell. In this case, explanations of crystallization behavior belonging 
to the produced nanocapsules can be again associated to the crystal 
grow in a confined and curved volume of a droplet, where a TIPS 
process occurring at curved liquid/liquid-droplet interface can bring to 
an unusual polymer solution crystallization.  
In order to explore the crystalline structure of PLLA nanocapsules, we 
performed X-ray diffraction analysis. Figure 26c shows the X-ray 
diffraction patterns obtained from PLLA at different polymer 
concentrations, when the primary emulsion is processed at fixed 
pressure of P=2000 bar. The two main peaks at 2~16.60° and 
2~19.00° match with the same reflections of the PLLA powder (Figure 
27) and allow us to index them as the (200)/(110) and (203)/(113) of the 
optical pure PLLA α crystalline form, respectively1.  
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Figure 27: XRD  pattern of PLLA powder. 
By changing the PLLA concentration from 0.1 wt/v % to 1.5wt/v% no 
changes in the position of the main peaks are observed. It is important 
to point out that, at a melting temperature Tm of 165°C, other different 
crystal forms could have been induced. However, XRD patterns reported 
in Figure 26c only show peaks related to α crystalline form, excluding 
definitely the presence of different crystalline phases.  
Further investigations on crystallinity grade of PLLA nanocapsules were 
obtained with IR measurements. In particular, PLLA nanocapsules 
suspension is frozen in liquid nitrogen and then freeze dried to obtain a 
powder for IR measurements.  
As reported in the graph below (Figure 28), characteristics peaks of 
amorphous and crystalline phase of PLLA at 870.75 cm-1 and 756.06 cm-
1 respectively, are observed in our nanocapsules. Moreover, presence of 
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peak at 1755.56 cm-1 assigned to the carboxyl stretching vibration, at 
1453.2 cm-1 related of asymmetric CH3 bending mode, and at 1382.54 
cm-1 for CH3 symmetric and asymmetric stretching mode were found 
and assigned to amorphous phase. In addition, peak related to C-O-C 
stretching mode and CH3 rocking mode are assigned to crystalline region 
and observed at 1184.26 cm-1. Finally, the peak at 1088.92, of C-O-C 
stretching mode is related to both amorphous and crystalline regions 
while, again, at 1045.75 cm-1 peak of C-CH3 stretching mode and CH3 
rocking mode are observed. 
 
Figure 28: IR spectra of PLLA powder and PLLA nanocapsules. 
LOADING CAPABILITY AND RELEASE MECHANISM 
Loading capability and release mechanism of the produced 
nanocapsules were investigated and fluorescent capability were 
86 
 
demonstrated, as reported in Figure 29a-c, where nanocapsules having 
different diameter were observed by Stimulated Emission Depletion 
(STED). Peculiar behavior of release mechanism is showed in Figure 29d.  
 
Figure 29: Loading capability and release mechanism. a-c, STED high resolution images of 
randomly dispersed fluorescence of (a) 250 nm, (b), 115 nm and (c) 95 nm; d, Effect of polymer 
concentration on drug release profiles of loaded nanocapsules; e, drug entrapment as function 
of size and shell thickness for different % of dye loadings. 
In particular, cumulative release was conducted on nanocapsules of 
different size and shell thickness. The cumulative dye release from our 
nanocapsules is displayed for nanoparticles of size ranging from 70 to 
250 nm.  Release experiments were repeated three times and all the 
profiles obtained were almost superimposable. In the cumulative 
curves, it can be seen that real release is starting at different time 
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according to the nanocapsules shell thickness and that, for higher 
polymer concentration, a first slight release is observed, maybe due to 
the absorption of the dye within the polymer shell. The sample prepared 
at higher PLLA concentration, besides showing an increase in their mean 
diameter, are also giving a slight increase of the loading capacity of 
hydrophilic compounds from about 25%, calculated on a weight 
percentage basis, to a minimum of 10 % that can be incorporated into 
smaller nanocapsules. A different situation is observed in the case of 
lipophilic compounds or metal nanoparticles where higher 
encapsulation efficiency is reported (more than 80%). Curves in Figure 
29d reveal a release mechanism typical of a nanocapsular structure by 
degradation of thin wall of the capsules leading to all-or-nothing cargo 
release. This characteristic is extremely important so that delivery 
vehicles could be later treated to be responsive to their local 
environment such that they retain their cargo until their target is 
reached, whereupon complete release should take place. In this 
framework, it is important to point out that this burst release via wall 
erosion can be regulated by tuning shell thickness of the nanocapsules 
through variation of polymer concentration.  
In order to investigate payload capability of the nanocapsules, together 
with Chromeo 488, other compounds have been easily incorporated in 
the developed nanocapsules such as Rhodamine B, Nile Red and 
Gadolinium Chloride, Superparamagnetic iron Oxide nanoparticle (SPIO). 
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Thus, drug content of the process at different condition is showed in 
Figure 29e.  
 
 
 
 
THERMODYNAMIC INTERPRETATION OF THE PROCESS 
Generally, TIPS technique is based on changes in thermal energy to 
induce the de-mixing of a homogeneous polymer solution into a two or 
multi-phase system domain. In a classical scenario, when the phase 
separation occurs, the homogenous solution separates in a polymer-rich 
phase and a polymer-poor phase, usually either by exposure of the 
solution to another immiscible solvent or by cooling the solution below 
a binodal solubility curve, where a liquid–liquid phase separation or 
solid–liquid de-mixing mechanism can occur20; 21; 22; 23, as described in 
Figure 30d. 
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Figure 30: Schematic representation of demixing of polymer solution in a nanoconfinement. a, 
Phase morphologies influenced by topological forces. Phase separation patterns are showed 
by cooling the system at a quench Temperature.  In detail, an emulsion droplet containing a 
polymer solution is cooled below Cloud Point condition (phase 1). At a certain Temperature, 
phase separation occurs within the droplet (topological nanoconfinement) which inhibits 
chains from free configurations and pushes them in higher energy state similar to a spinodal 
phase. This increase of the polymer energy leads to a transition to a more ordered structure, 
where the polymer sets in a nanocapsular morphology at low free energy (phase 2). While 
cooling the system, a further segregation will be originated such that chain bending will be 
preferred.  b and c, Schematic representation of nanocapsules and cross section highlighting 
crystal lamellae within the shell. d, Standard polymer segregation and phase diagram 
displaying spinodal curves, within the coexistence curves and uppercritical point. e, Energy 
content of the different phase steps to obtain nanocapsules.  
After that, the solvent is extracted by lyophilization and, depending 
upon the system and phase separation conditions, different 
morphologies and characteristics of the materials can be obtained. In 
this framework, Poly Lactic Acid (PLA) has been largely studied to 
produce two main types of morphologies by TIPS: globular-like and 
membrane-like. However, PLA is a slow-crystallizing material1, and 
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crystallization phenomena of PLLA by TIPS are not very effective in 
terms of control of process-time and material properties.  
However, when TIPS is performed in a nanoconfinement, the 
macromolecules experience an entropy variation of crucial importance 
for the free energy change accompanying formation of morphologies 
and crystal domains24; 25; 26. The geometrical constraints applied to a free 
unperturbed polymer chain reduce the number of available 
conformations of the chain and introduce additional interactions 
between polymer segments and the surface. For spherical 
confinement27; 28, contribution of the entropic penalty is more complex 
because of excluded volume effects. Indeed, there are two factors 
influencing the effective coordination number and, hence, the 
conformational entropy of the polymer in the vicinity of the interface: 
the excluded volume of the polymer segments and the excluded volume 
of the obstacle. On the basis of the above principle, here we study the 
effect of quenching of the ternary system, PLLA-Dioxane-Water, not in a 
macroscopic environment but in a single droplet of a water-in-oil 
nanoemulsion. We performed our experiments in the low polymer 
concentration region (Figure 30d), where a solvent rich phase 
formation, as well as globular-like morphology, is favorite by decreasing. 
Briefly, as reported in Figure 30a-c, a polymer ternary solution at fixed 
temperature and composition is used as disperse phase while a PVA 
aqueous solution forms the continuous phase (phase 1). Typically, 
keeping constant the temperature and emulsifying the system under 
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high shear rate, a mean droplet size lower than 500 nm is obtained. At 
this point, any emulsion droplet becomes as a single system containing a 
ternary polymer solution (phase 2). The last step consists in the 
instantaneous cooling of the emulsion into a metastable region. Under 
these conditions, the thermodynamic barrier for the formation of a 
crystalline phase is lower than that for the formation of an amorphous 
phase, and so, PLLA molecular chains overcome the potential barrier 
and chain folding will occur also at high cooling rate, in order to 
maintain the thermal dynamic equilibrium. In details, if trapped in an 
initially spherical nanoconfinement, the polymer will be unable to fully 
adopt all its possible conformations through thermal fluctuations, with 
the consequence that chain segment alignment will probably 
correspond to the lowest available energy status of the polymer system. 
Subsequently, some folded chains will immediately aggregate, leading 
to the formation of crystal nuclei within the droplet. However, at this 
point, further aggregation phenomena are prevented by a large energy 
barrier due to intersegment attractive or repulsive interactions, volume 
effects and presence of antisolvent and only the development of 
interconnected domains characteristics of spinodal decomposition can 
proceed. Finally, having a reduced number of available conformations 
because of the nanoconfinement and trying to be away from the 
antisolvent, instead of forming an extended or isolated structure, the 
preformed crystal nuclei will adopt an interconnected nanocapsular 
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structure to reduce excess of free energy (phase 3), as reported in 
Figure 30e.  
In the framework of the traditional thermodynamics, we can make some 
considerations: when phase3 is carried out in a macroscopic system, 
polymer chains are able to adjust to infinite configurations to reduce 
their free energy, with the consequence that the formation of a 
crystalline structure is not energetically favorable at high cooling rate. In 
a nanoconfined system, instead, chains can adjust a reduced number of 
configurations to decrease the excess of free energy, with the 
consequence that chain folding becomes one of those conformations 
able to bring the system to a reduction of the entropic penalty.  
In summary, thermally induced phase separation in a flexible 
nanoconfinement can promote a spinodal-like regime where even the 
smallest fluctuations can grow as crystal nuclei because of the shallow 
energy barriers, driving the formation of nanocapsular structures when 
surface energetic contributes to create an interface are predominant, in 
comparison with the volume energetic contributes. Our observations 
demonstrate for the first time how morphologies resulting from TIPS 
within a nanoconfinement can be extremely different from those 
obtained from traditional TIPS in a macroscopic environment. These 
theoretical considerations are illustrated here for the case of PLLA 
formation but could be generalized for many other polymer systems. 
Moreover, the model we propose contributes to advancing the 
understanding of how polymorphism of some polymers could be 
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influenced by an energetic nanoconfinement and how this knowledge 
could influence both fundamental thermodynamic understanding and 
technological advances in design and scale-up of processes
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 CHAPTER III: AQUEOUS CHANNEL MANIFESTATION 
AMONGST BIODEGRADABLE NANOMATERIALS FOR 
FAVORABLE GADOLINIUM ENTRAPPING 
INTRODUCTION 
Enduring volatile evolution of medical imaging technologies have 
taken place over the past few decades and nowadays play a principal 
role in clinical oncology. Along with allowing clinicians to see where a 
tumor is located in the body, molecular imaging also visualizes the 
manifestation and commotion of unambiguous molecules (e.g., 
proteases and protein kinases) and biological processes (e.g., 
apoptosis, angiogenesis, and metastasis) that influence tumor 
behavior and/or response to therapy1. Contemporary clinical cancer 
actions require specific information such as the exact tumor location; 
how large is it?; Its confinement to a small area, or its blowing out to 
lymph nodes? etc. Through the application of traditional anatomical 
imaging methods such as computed x-ray tomography (CT), magnetic 
resonance imaging (MRI), and ultrasound (US), the aforementioned 
interrogations are being dealt with ever-growing spatial resolution2-4. 
MRI provides an obligatory tool to increase the compassion and 
selectivity of cancer diagnosis; especially in the early stages of tumor. 
The production of high-resolution three-dimensional maps 
demarcating morphological topographies of the specimen provides 
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an edge to MRI comparatively. To establish MRI as a key imaging 
modality for cell tracking studies, it is necessary to develop a new 
generation of high-sensitive MRI contrast agents that could allow for 
the efficient detection of labeled cells in vivo. For enhancing the 
differentiation between tissues, approved metallic contrast agents 
such as Mn (Teslasca®), Gd (ProHance®, Dotarem® & Magnevist®) and 
Fe (Endorem®, and Feride®) have been used5-8. Fe comprising 
nanoparticles (NPs) are being used as cellular probes; they provide a 
very sensitive “negative” contrast effect, which enables single cell 
detection. However the induction of a negative contrast effect due to 
strong magnetic susceptibility of iron oxide nanoparticles greatly 
exceeds the exact area where implanted cells are located. Moreover, 
these relics encumber the demarcation of fine vasculature and 
functional geographies around the labeled cells, and thereby make 
impossible cell quantification based on contrast enrichment9-11. 
It was considered that the NPs could be one of the ideal molecular 
probes as the MRI contrast agent and the novel NPs had already been 
developed for molecular imaging12. Although NPs have revealed 
attractive potential as molecular imaging contrast agent, loading NPs 
with Gd postures challenge in the development of targeted contrast 
agents. Three of the common methods being reconnoitered are (i) 
Encapsulating Gd in the core space of the NPs; (ii) Self-assembling & 
(iii) Chemical conjugation of Gd on the exterior of the NPs.  In 
combination with gadolinium, polymer micellar NPs are very 
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promising because of their aptitude to deliver positive contrast (i.e., 
T1-weighted images), robust structural features, and simple 
fabrication. In such a micelle assembly product, the rate of water 
exchange is similar to that observed in Gd–DTPA, because of the 
exposure of Gd complex in the exterior shell layer of the micelle13. 
However, due to non-biocompatibility of the DOTA, there is 
necessitated endeavor to study some biocompatible contrast agents. 
MRI is a powerful medical diagnostic technique: it can penetrate 
deep into tissue, provide excellent soft tissue contrast with sub-
millimeter resolution, and does not employ ionizing radiation. 
Targeted contrast agents provide an additional layer of molecular 
specificity to the wealth of anatomical and functional information 
already attainable by MRI. However, the major challenge for 
molecular MR imaging is sensitivity: micromolar concentrations of Gd 
(III) are required to cause a detectable signal change, which makes 
detecting proteins by MRI a challenge14. Excretion of Gd-based 
contrast agents take place in un-metabolized form, but 
biodegradability in aqueous test systems is still an issue15. Due to 
their high polarity and good water solubility they exhibit a long half-
life16. 
Recently, nanoparticles prepared with biocompatible and 
biodegradable polymers, such as poly (D, L-lactide-co-glycolide) 
(PLGA) or poly (D, L-lactide) (PLA), have attracted much attention due 
to their favorable physico-chemical characteristics in terms of safety, 
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stability, the relative ease of large-scale production, and lack of 
intrinsic immunogenicity etc17-19. Significantly, idyllic MRI contrast 
agents voluntarily paves the way to degradation and clearance from 
the body after its functions were over. Thus, biocompatible and 
biodegradable nanoparticles, possessing significantly low or trifling 
safety risks and convenient preparation in large quantities, have been 
suggested as novel candidates for molecular imaging contrast 
agents20. Block copolymers of poly lactic acid (PLA) and polyethylene 
glycol (PEG) are few of the commonly used polymers with hydrophilic 
and hydrophobic blocks which allows the formation of a stable nano-
particulate suspension in an aqueous solvent, where PLA chains 
predominantly form the core and PEG chains are located outside21. A 
systematic variation in their chemical structure, composition, size, 
and architecture; block copolymers offer advantages in tuning their 
shape and functionality in comparison to conventional amphiphiles 
such as low molecular weight surfactants and lipids22-24. Recent 
studies have enriched the scope of block copolymer self-assembly by 
increasing the diversity of supramolecular aggregates such as 
micelles25-27, vesicles24, 28-32, and toroids33-36 formed in both aqueous 
and organic environments or even in the mixture. Diblock PLA-PEG 
copolymers and triblock PLA-PEG-PLA copolymers allow modulation 
of the biodegradation rate, the hydrophilicity, and the mechanical 
properties of the copolymers37. Herein we present 
temperature/time-reliant self-assembly driven simple approach for 
the development of biocompatible nanostructures for MRI. Endeavor 
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of the present research was to develop Gd loaded PLA-PEG-PLA NPs 
as the molecular MRI contrast agents to efficiently target tumor. A 
low molecular PLA-PEG-PLA have been designated to prepare well-
demarcated NPs through optimization of kinetics of the self-assembly 
viz a viz temperature/time/concentration. The 
hydrophobic/hydrophilic moieties of block copolymer nanoparticles 
(BCN) were employed to adsorb GD+3 at the surface of BCNs to 
achieve multifunctional biodegradable NPs for MRI. The 
paramagnetic properties of the BCNs designed here compare 
sympathetically with Gd-based agents that have previously been 
reported. For example, Gd-labeled shell-cross-linked nanoparticles 
(40nm diameter) exhibit an R1 of 39mM
-1 s-1per Gd (0.47 T) but 
possess only 510 Gd per particle, which results in an R1 of 2x104 mM
-
1s-1 per nanoparticle38. This relaxivity is significantly lower than the 
paramagnetic BCNs presented here. 
MATERIALS AND METHOD 
Materials 
For engineering the block copolymer nanoparticles (BCN), a low 
molecular weight Block polymer (PLA-PEG-PLA, Mw=1500-900-1500 
Da) was purchased from Sigma Aldrich. Intended for dispersed phase, 
various organic solvents such as N,N-Dimethylformamide (DMF) and 
acetone were also procured from Sigma Aldrich. And the Gadolinium 
Chloride (CdCl3) used for loading the BCN have been purchased from 
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Sigma Aldrich. Extra pure Millipore water was used for the self-
assembly process. 
Procedural Methods 
In a distinctive procedure three different amounts 1, 5 &10mg of 
GdCl3 in various round bottom flasks respectively were allowed to 
dissolve for best labeling efficiency under increased aspiration. The 
dispersed phase was prepared by solubilizing stipulated 
concentration of the block copolymer in 3ml of the acetone. A 
homogeneous dispersed phase was prepared through ultra-
sonication for 5 minutes at amplitude of 20%. Under constant and 
moderate stirring the dispersed phase was poured into 45ml of water 
at a rate of 1ml/min. Along with the room temperature, the 
aforementioned pathway was also followed to prepare the BCN for 
different amounts of the polymer at 40°C. Solvent-evaporation self-
assembly during the aforementioned method was allowed for 
enhanced time intervals of 72 hours at least, while the morphological 
advances were observed at various time intervals. 
Techniques 
Dynamic Light Scattering (DLS) 
The hydrodynamic diameter of freshly prepared BCN were 
continuously observed by a Malvern Zetasizer (Nanoseries) at 
stipulated time intervals up to 24 hours. Surface Zeta Potential of the 
BCN was also observed through the same instrument at definite time 
intervals.  
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UV-Vis measurements 
UV-visible spectra of solutions will be measured by Cary 100Scan UV-
vis spectrophotometer (UV0901M191) in the wavelength range of 
200-900nm. The characteristic UV-vis absorbance properties of 
colloidal BCN solution in the presence of different 
concentrations/temperatures have been performed by the 
dissolution/adsorption of dye in block copolymer solution.  
Isothermal titration calorimetry (ITC) 
The calorimetric experiments were performed with a Nano-
ITC instrument (TA Instruments—Waters LLC 109 Lukens Drive New 
Castle, DE 19720). All heat effects arising from the injection of the 
solution in the syringe solution into the sample cell solution are 
actively balanced by a calorimeter feedback system keeping the 
sample cell and reference one at the same temperature. The 
calorimeter sample cell was filled with acetone and the titration 
syringe was loaded with the TBP solution in acetone of a stipulated 
concentration. Each titration consisted of twenty, 2.5μL injections at 
300-second intervals with stirring speed of 150 rpm. A 3000-second 
baseline was collected before the first injection and after the last 
injection. Prior to starting the titration, the calorimeter was 
equilibrated to a baseline with a drift of less than 100nW over a ten-
minute period. Two to three individual measurements were 
performed for each system at different temperatures. The 
experimental data were analyzed using the NanoAnalyze software for 
ITC as provided by TA instruments. The thermodynamic properties 
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using the mass-action model were obtained by applying a non-linear 
regression routine based on the method of simulated annealing to 
the experimental data. 
Field Emission Scanning Electron Microscopy (FESEM) 
FESEM instrument from Ultra-plus Zeiss at accelerating 
voltage of 5-20kV have been used for all SEM studies. For liquid 
samples the drops were dried on a glass mounted on a stub while the 
ultra-filtered samples have been observed by fastening the 
polycarbonate membranes on the stub.  
Transmission Electron Microscopy (TEM) measurements 
The shape and size of BCN have been characterized by 
transmission electron microscopy (TEM). The samples were prepared 
by mounting a drop of self-assembly solution on a carbon coated Cu 
grid and allowing it to dry in air. These samples have been observed 
with the help of a FEI CM10 transmission electron microscope 
operating at 120 kV. The system has been provided with an 
intensified video camera to assist in alignment and a slow scan CCD 
camera. Final images can be recorded on CCD. 
ICP-MS (inductively coupled plasma mass spectrometry) 
ICP-MS makes it possible to distinguish between different 
oxidation stages of metal ions (speciation) and between free and 
bound ions, and thus to determine the effects of the addition of BCNs 
on the stability of the gadolinium. Aqueous solutions of Gadovist and 
Magnevist with a gadolinium concentration of 1 mg/L acted as MRI 
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contrast agents. TBP concentrations of 5, 10 and 20 mg/L were used 
to investigate the stability of the gadolinium contrast agents. 
Fourier Transformation Infrared spectroscopy 
FTIR spectrum was measured by using a RZX (Perksin Elmer) Fourier 
transform infrared spectrometer at room temperature in the range of 
4000-400 cm-1 with sample mild in KBr. 
Results and Discussion 
Gd-labeled biodegradable functionalities have been 
developed as MRI agents by using GdCl3 and time/temperature 
driven simple block copolymer self-assembly progression. These 
biodegradable & biocompatible molecular contrast agents for tumor-
sensing have been prepared by encapsulating/loading gadolinium 
onto BCNs (shown schematically in Fig.3) of low molecular weight 
block copolymer. The hydrodynamic diameter was determined by 
dynamic light scattering (DLS). For observing the formation of BCN in 
a detailed fashion and also for comparison, their formation in the 
absence of GdCl3 was also carried out and characterized rigorously by 
DLS & variety of techniques revealed in the experimental section. 
Fig.1 demonstrates the dynamic light scattering profile of the BCNs 
self-assembly in DMF. The BCNs were characterized rigorously, by 
employing DLS which demonstrated that for a lower concentration of 
the block copolymer, nanostructures were negatively charged having 
a negative zeta potential, ζ around 35mV and possessed number-
averaged hydrodynamic diameter about 100 nm. During the course 
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of measurement it have been observed that after a certain threshold 
of time duration of the self-assembly process, the same did not affect 
the size up to a great extent while somewhat similar trend was 
observed for ζ of the BCNs. Few of the interesting annotations of the 
present study were observed in case of the concentration of the 
block polymer.  
 
Fig.1: a) Surface Zeta-potential and b) Hydrodynamic Size-Evolution 
of self-assembled BCNs @Room Temperature in DMF as a dissolving 
medium. 
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As established from Fig.1b, the hydrodynamic diameter of the 
BCNs have been observed ≤100 for a block copolymer concentrations 
of 0.43 & 0.86mM, while it was ≤150 for two of the higher 
concentrations of the block copolymer self-assembly. This upsurge in 
size at elevated levels of concentration could be driven by an 
increase in viscosity of the self-assembly solution there by making the 
emulsion more viscous. The arduous time and concentration oriented 
study of the BCNs via DLS suggested considerable decrease in surface 
zeta potential with the increase in concentration of the block 
copolymer in the self-assembly process, suggesting thereby instability 
of the BCNs at elevated levels of concentration. This may be 
attributed to greater amount of polymer present in the same volume 
of dispersed medium, probably paving the way for enhanced 
electrostatic interactions among various polymer moieties in far post-
micellar regions and same reflection gained strength from electron 
microscopy profiles of the BCNs demonstrated in the later part of this 
section.  
Since, nonionic surfactants with a PEG hydrophilic segment 
show a very strong temperature dependent micellization process39, 
therefore temperature dependence of BCNs self-assembly was also 
considered through DLS and other techniques. The DLS profiles of 
BCN self-assembly have been presented in Fig 2 demonstrating a 
marked size difference in BCN from that of at 25°C. Evidently from 
the DLS profiles dilulge that BCN@lowest concentration of the block 
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copolymer illustrates a negative zeta potential of around 35-40, 
making these very BCNs more stable in comparison to the BCNs 
prepared@highest concentration which possess a negative zeta 
potential of about 15. In terms of size of these morphological 
architectures we had obeserved an increase in size of BCNs upto 
about 175nm. One of the point worth mentioning during the course 
of present discussion is that monodispersity of nanostructures is not 
very ideal and therefore we observed a diversified morphological 
structure evolution in terms of shape as well as size (an entirely 
separate study is underway). Same observation gained prominence 
after we progressed through the electron microscopic studies 
(presented in the later part of the discussion). Which may be caused 
due to highly unstable and complex character of the block copolymer 
viz-a-viz different types of monomeric identies involved none of 
which have identical properties in terms of hydrophobicity and 
solubility in similar kind of solvents. Moreover two PLA monomers on 
the edges and one PEG monomer present in the middle provides 
complexity to the block copolymer character. 
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Fig.2: a) Surface Zeta-potential and b) Hydrodynamic Size-Evolution of 
self-assembled BCNs @40°C 
 
Because of the the strong temperature dependence of 
hydrophilic PEG segment the biggest difference in the BCNs for 40°C 
have been noticed in terms of the shape dependent morphological 
effects. Moreover, the edifice of triblock copolymer micelles 
becomes a feeble function of concentration, but changes swiftly with 
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temperature40, with association number accumulative and micelle 
becoming drier, as the temperature is increased and water exorcised 
from the micelle core41. SEM micrographs represented in Fig.4, 
evidently establish the shapes of BCNs predominently spherical. 
Moreover a greater temperature provides necessary plateform for 
the nucleation for the nanostructures evolution towards an ordered 
geometry. Some of the traces in Fig.4a,b inaugurate that higher 
temperature leads to the aggregation of nanostructures. At room 
temperature although the aggregation was totally lacking and the 
morphology of the BCNs was not orderly spherical (Fig.6a). 
   
b 
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Fig.3: a,b Scanning electron micrographs of BCNs prepared at 40°C. 
 
The dissolving mediums i.e. solvent contributes in the self-assembly 
upto a marked extent in terms of diversified properties like size etc of 
nanostructures. The present study deals with two different solvents 
DMF and acetone as the dissolving medium for the block copolymer 
in question. Available literature42 is enough to suggest that PLA swells 
when allowed to dissolve in DMF, while it get solubilized completely 
a 
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in acetone. This inference also gained prominense from the  
copolymer self-assembly appearance, which was a bit turbid in case 
of DMF, unlike acetone. This  could be the reason for a much larger 
size of the BCNs in case of DMF as compared to that of acetone 
(electron micrographs presented in later part Fig.6 onwards). 
Aforementioned results reveal the electron microscopic and DLS 
profiles of BCNs in a polar aprotic solvent DMF43. 
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Fig.4: a) Surface Zeta-potential and b) Hydrodynamic Size-Evolution of 
self-assembled BCNs @Room Temperature & 40°C in acetone as a 
dissolving medium 
 
Acetone is a good solvent for PLA, while comparatively it exhibits 
lesser solubility when dissolved in DMF. In a good solvent the PLA 
part of the TBP swells more in comparison to a poor solvent, leading 
there by to smaller nanoparticles in the later. Therefore the size of 
BCNs obtained in DMF (Fig.1b) is predominantly lesser in comparison 
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to that obtained in acetone (Fig.5b) as evidenced from the DLS 
profiles of the same. Various concentrations of the TBP demonstrate 
a size and zeta potential distribution as embodied in Fig.5.  
Fig.6 unveils the scanning electron micrographs of TBP micelles at the 
lowest TBP concentration we tried during the passage of our self-
assembly progression. After enhanced number of experiments for the 
cmc determination of TBP we had an idea about the cmc of the TBP. 
ITC was extensively tried to elaborate about cmc determination of 
the triblock polymer under study. The micrographs clearly 
demonstrate existence of cylindrical and spherical micelles in the 
periphery and inside the compound micelle. The size of these 
micelles have been observed as small as 30-50nm. With the passage 
of increasing [TBP], size of the micelle nanostructures increases and 
morphologically these soft nanostructures are converted into 
comparatively hard ones which can be easily attributed to Fig.7. The 
black spots on soft micellar nanostructures in Fig. 6b may be 
attributed to burns caused by elevated levels of magnification during 
SEM observation. Increasing the magnification during SEM 
observation does not exhibit burns on the nanostructures thereby 
making the later hard, unlike the micelles appearing and getting 
burns at increased levels of magnification for experiments carried 
around CMC of the TBP. Although polymeric micelles exhibit various 
biological claims but from MRI and drug delivery point, fondness 
always subsists for spherical and durable morphologies rather than 
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soft micellar nanostructures due to unstable character of the 
polymeric micellar nanostructures.  
 
 
Fig.5: SEM of TBP micelles at lowest [TBP] (around cmc) prepared at 
room temperature; a) compound-micelles and b) higher 
magnification SEM construction of a compound micelle.  
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Fig.6: a) Scanning electron micrographs of BCNs at room 
temperature at moderate [TBP]; b) higher magnification SEM of 
BCNs. 
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Fig. 7: TEM Image of the obtained core shell particles 
Numerous experts during the decade have explored micellization of 
block copolymers up to a great deal but the novelty of present work 
is the formation of predominantly spherical nanostructures of a very 
low molecular weight TBP in a phased fashion. To the best of our 
knowledge, we didn’t encounter any literature involving well defined 
nanostructure accumulation out of very low M.W. TBP. Further, 
owing to our interests in the field of MRI and targeted drug delivery, 
the emphasis at the beginning of the present study was laid down for 
designing spherical nanostructures with a simplest possible path. 
Cryogenic TEM (cryo-TEM) technique demonstrates the exact 
morphology of polymeric micelles without being influenced by drying 
the samples as in case of traditional TEM/SEM or even a bit of 
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alteration of exact nanostructure size and morphology due to 
vacuum pressure for cellulose membrane filtration of the samples for 
SEM. Compared to bright-field TEM where samples were dried on a 
solid carbon-coated grid, cryo-TEM preserved the size and 
morphology of micelle nanoparticles in the hydrated state. Cryo-TEM 
measurements showed that micelle diameters are… 
ITC is meanwhile a standard method to determine the critical 
micelle concentration (CMC) and the heat of demicellization, Hdemic, 
i.e. the molar enthalpy of transfer of polymer monomers from a 
micelle into solvent44-47. ITC is a widely used method to determine 
CMC values of surface active agents. In the literature, ITC has been 
used as a unique technique for studying of micellization 48-52or used 
with other complementary techniques such as fluorescence 
spectroscopy53, conductivity54, potentiometric titration53 and 
differential scanning calorimetry53. Corresponding determination of 
the micellization enthalpy is another advantageous on part of ITC and 
CMC later can be further used to determine the Gibbs energy of 
micellization48-52. Following relation can be drawn out of ITC, where 
 
  ∆Hmic = -∆Hdemic 
∆H mic= Enthalpy change when surfactant monomers cooperatively 
aggregate into micelles & ∆H demic = Enthalpy change when surfactant 
monomers de-micellize into surfactant monomers at CMC. Two types 
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of enthalpograms were obtained; nonsigmoidal and sigmoidal curves 
respectively (Fig. 7 & Fig. 8) for room temperatures. According to the 
type of curve obtained, two methods were used for analyzing the 
enthalpograms. When sigmoidal curves were obtained, the CMC 
corresponded to the concentration where the first derivative of the 
curve displayed a maximum; whereas the heat of micellization (∆Hmic) 
was equal to the enthalpy difference between the two extrapolated 
lines as shown in Fig 8. The curves that did not present clear 
sigmoidal features were analyzed by a data treatment analogous to 
the one suggested by many authors. The enthalpograms may be 
categorized into two concentration varieties. During the first 
injections the concentration of the TBP molecules in the sample cell 
stays below their cmc and large almost constant enthalpic effects 
appear due to demicellization of the micelles, dilution of the micelles 
and dilution of the resultant monomers. The second section of the 
piercing increases (Fig. 7a) or decreases (Fig. 8) of the heat 
possessions specify that the cmc of the block polymer is reached in 
the sample cell. In the third concentration range the further addition 
of a concentrated micellar solution to the existing micellar solution in 
sample cell leads to heat effects due to the dilution of micelles. 
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Fig.8: Nano-isothermal calorimetry (Nano-ITC) of the block copolymer 
Reconnaissance was that the incorporation of gadolinium didn’t 
appear to significantly impact BCN size. Probable manifestation of 
aqueous channels because of the occurrence of PEG in the interior up 
to a marked extent, along with that on the exteriors of BCNs may 
lead to entrapment of some of gadolinium amongst the aqueous 
channels (Fig.3) which may be a contributing factor for insignificant 
size increase after introduction of Gd. It is likely that the BCN size 
could not be further reduced due to the energetic constraints 
imparted by the thick hydrophobic domain. This is significantly larger 
than the hydrophobic domain of most polymeric micelles, which are 
typically 3 nm in thickness55. Comparative improvement in structural 
stability of the BCN architectures has made them an attractive 
alternative to polymeric micelles, which often encounter limitations 
in clinical applications by their low stability in circulation. In spite of 
much of endeavor on part of investigators worldwide in the field of 
monomeric and diblock polymers; the choice of a triblock polymer in 
the present study could be attributed to the hypothesis that 
morphologically we expect the presence of PEG on the corona as well 
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as marginally in the core of BCNs and this may monitor in evading a 
capture by reticuloendothelial systems (RES) and remain in 
circulation for a longer duration. Critical micellization allows for 
vesicle formation while post-micellization concentration paves the 
way for precise time-tuned control of sequential block collapse and 
micelle vesicle into BCNs, which might be harmonized with cancer-
drug encapsulation with essentially no drug losses. Post-micellization 
regions have been demonstrated to produce benign, stable 
nanoparticles made of PLA-b-PEG-b-PLA triblock copolymers that are 
not only solvent-free and drug-rich, which reduces the body exposure 
to the excipients, but also nearly burst-release-free owing to the 
presence of aqueous/PEG channels. Which may reduce if not 
eliminates its toxic side effects while enhancing its therapeutic 
efficacy. 
 
Fig.9: Probable model of aqueous channels propagated amongst BCNs 
 
Conclusions 
Self-assembly driven simple and robust attitude have been developed 
to prepare well-delineated BCNs of a very low molecular weight block 
Aqueous Channels
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copolymer. The temperature driven self-assembly generates stable 
nanostructures in comparison to that at room temperature. Elevated 
level of temperature provide a higher and rapid nucleation platform 
for the self-assembly. Although higher levels of concentration of the 
block copolymer results in the BCNs with higher size (≤150); but 
evidently zeta potential (35-40) suggests stability of the BCNs at a 
lower concentration of the polymer. By choosing a suitable system 
viz a viz  dissolution and dispersed medium for the block copolymer 
constituting monomers, it is reasonable to expect that this simple 
one-step simple route can be extended to obtain  stable 
nanostructures as a result of the micellization of the polymer. The 
manifestation of an aqueous environment and the 
relocation/migration of hydrophilic parts of the block copolymer 
towards exteriors of the nanostructures have been concluded on the 
basis of the hydrophilic character of the PEG segment of the block 
copolymer. Moreover, due to incomplete migration/relocation of the 
PEG segments towards the exteriors, some part of it remained 
entrapped in the interiors as well. This PEG present in the interiors of 
the nanostructures may manifest via aqueous channels which may 
prove a guiding force for Gd entrapment among the interiors of the 
nanostructures. 
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CHAPTER IV: PRELIMINARY DATA ON DEPOSITION OF 
BLOCK COPOLYMER ON NANOCAPSULAR STRUCTURES TO 
BE APPLIED IN THE THERANOSTIC FIELD 
INTRODUCTION 
There is a vast and growing interest in the medical applications of 
polymer micelles containing di-block or tri-block-copolymers that 
consists of hydrophilic and hydrophobic blocks. The micelles cores 
can be loaded with hydrophobic or hydrophilic drugs that can be 
released by a change in pH or another external factor. About the 
enormous advantages of the nanocapsular we have already discussed 
in the previous Chapter II, so, in this last Chapter we have thought to 
take advantages from the combinations of these two precious 
characteristic by covering our semi-crystalline nanocapsules with the 
TBP. This new architectures could allow us to use the peculiar melting 
properties and release behavior of the nanocapsules in combination 
to the ability of the TBP of perform enhanced MRI.1  
MATERIALS AND METHOD 
Materials 
For engineering the block copolymer nanoparticles (BCN), a low 
molecular weight Block polymer (PLA-PEG-PLA – Mw=1000-10000-
1000Da) was purchased from Sigma Aldrich. Intended for dispersed 
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phase, various organic solvents such as N,N-Dimethylformamide 
(DMF) and acetone were also procured from Sigma Aldrich. And the 
Gadolinium Chloride (CdCl3) used for loading the BCN have been 
purchased from Sigma Aldrich. Extra pure Millipore water was used 
for the self-assembly process. PLLA Nanoparticles have been 
produced by the method reported in Chapter II. 
Methods 
Isothermal titration calorimetry (ITC) 
The calorimetric experiments were performed with a Nano-
ITC instrument (TA Instruments—Waters LLC 109 Lukens Drive New 
Castle, DE 19720). All heat effects arising from the injection of syringe 
solution into the sample cell solution are actively balanced by a 
calorimeter feedback system keeping the sample cell and reference 
at the same temperature. The calorimeter sample cell was filled with 
water and the titration syringe was loaded with the aqueous TBP 
solution of a stipulated concentration. Each experiment consisted of 
twenty five injections each of 2μL at 180 second intervals with a 
stirring speed of 150 rpm. A 3000-second baseline was collected 
before the first injection and after the last injection. Except the 
aforementioned room temperature, parallel experiments have also 
been tried at various temperatures of 30°C, 35°C & 40°C. Prior to 
starting of the titration, the calorimeter was equilibrated to a 
baseline with water in water titration so as to standardize the 
instrument. The experimental data were analyzed using the 
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NanoAnalyze software for ITC as provided by TA instruments. The 
thermodynamic properties using the mass-action model were 
obtained by applying a non-linear regression routine based on the 
method of simulated annealing to the experimental data. So as to 
study the thermodynamics involved during a probable combination 
of PARTICLES with our TBP, separate experiments have been carried 
out by filling the Nano-ITC sample cell with PARTICLES and inserting 
the TBP through syringe. The addition pattern and the concentration 
of the TBP were kept same as was the case previously.  
Field Emission Scanning Electron Microscopy (FESEM) 
FESEM instrument from Ultra-plus Zeiss at accelerating 
voltage of 5-20kV have been used for all SEM studies. For liquid 
samples the drops were dried on a glass mounted on a stub while the 
ultra-filtered samples have been observed by fastening the cellulose 
membranes on the stub.  
Transmission Electron Microscopy (TEM) measurements 
The shape and size of BCN have been characterized by 
transmission electron microscopy (TEM). The samples were prepared 
by mounting a drop of self-assembly solution on a carbon coated Cu 
grid and allowing it to dry in air. These samples have been observed 
with the help of a FEI CM10 transmission electron microscope 
operating at 120 kV. The system has been provided with an 
intensified video camera to assist in alignment and a slow scan CCD 
camera. Final images can be recorded on CCD. 
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Results 
Starting from a particle concentration of 1mg/mL, we worked at 
different dilution ratio: 1:1, 1:2, 1.10, 1:50, 1:100. Our decision to 
work at 1:2 ratio was due to the absence of interferences in the heat 
signal. As showed in the graph a), because of the same height of the 
peaks only the contribution of the dilution was detected.  Two 
different TBP concentration were studied for this system: 6,67 mM 
and 13,35 mM. 
The reason to try these two concentrations is due to previous data 
related to the micellization of the TBP in water. Indeed, some 
experiments related to the CMC and CMT were performed in order to 
individuate the range of work.2,3 
 
Figure 3: Representation of the Block-copolymer depopsition on nanoaprticles after the 
injection 
As reported in Figure 1-c, a decrease in the energy rate is observed 
when the solution of the block copolymer is injected in the sample 
cell. We have attributed this behavior to the initial deposition of the 
TBP on the particles. It is important to notice that the exothermic 
effect in presence of the combination TBP-Particles is much higher if 
compared to the graph in Figure 1 A) and B).  
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Figure 4: Graphs resulting by Titration experiments. A) Heat vs Time resulting by the diluition 
of the particles within the cell. B) Range of concentration were TBP has already reached its 
critical micellar concentration able to for regular micelles and to cover the nanoparticles. C) 
Last results represent the injection the TBP at the concentration of 6,67 mM injected in the 
sample cell containing nanoparticle suspension 1:2 (0,5mg/mL) 
Enthalpy changes/injection were determined and the data was 
transformed and fit to an equation which shows the “injections” or 
"Mole Ratio = mole tritant/mole titrate". The line fit to the data in 
that panel is the best fit line at the selected concentration, Please 
note that the curve is sigmoidal, as showed in figure 3 
 
A 
B C 
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Figure 5:Integration of the Heat over the time course of the experiment. The µJ in each peak 
are plotted against the injection or the male ratio of tritant to tritate. 
Predominantly, the two interacting species are probably supposed to 
interact non-covalently. i.e. via surface hydrophobic patches. 
Specifically, electrostatic and dipole interactions & a precise pairing 
of H-bond donors and acceptors may pave the way for binding in the 
present case. Exposure of the hydrophobic core via aqueous channels 
of BCNs may deliver an opportunity for the PARTICLES to propagate 
hydrophobic interactions. ΔG regulates the track in which molecular 
binding equilibria will instinctively ensue, with more negative values 
of ΔG favoring higher affinity binding. Decisively, it may be realized 
that ΔG and its enthalpic and entropic ingredients depend upon 
differences between free and bound statuses for both of the 
interacting buddies. Indicative from Fig. 2, the value of ∆G can be 
calculated from the ∆H and ∆S values and a negative ∆G suggests that 
the molecular binding in the present case is favorable. 
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Conclusions and perspectives 
In this last Chapter some preliminary data have been reported 
related to the deposition of the BCN on the NCs. Further 
investigations are need to test the nature of this deposition. Indeed, 
CRYO-TEM in in ordered to evaluate the morphology as so IR to study 
the interaction between PLLA and Triblock copolymer are needed. 
Finally, the melting behavior and the theranostic properties of this 
new-formed system have to be insvestigated.  
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